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ABSTRACT 
Access to sanitary drinking water is a fundamental human right 
required for the continued prosperity of humanity.  As a result, the 
World Health Organization (WHO) has published water safety 
recommendations stating that drinking water supplies should contain 
no detectable coliforms in 100 mL of water.  Finding a single 
bacterial colony forming unit in that volume is akin to finding a single 
grapefruit dropped into Lake Erie, a size difference of approximately 
15 orders of magnitude.  Only traditional culture techniques are 
capable of such detection limits, and all require at least 24 to 48 
hours.  The United Nations Children’s Fund (UNICEF) has declared 
the need for detection devices to accomplish the abovementioned 
detection limits in much shorter time frames.  In response, we 
developed a series of bacteriophage-based biosensors with 
 detection limits that approach and achieve the aforementioned 
detection requirements in fractions of the time required for traditional 
culture techniques.  Our most rapid assay is capable of detecting 10-
20 CFU of E. coli in 100 mL of drinking water in only 5 hours.  Our 
fully quantitative assay only takes 12 hours and is directly compared 
to established methods.  The sensitivity of our rapid bacteriophage-
based detection technology is the result of multiple technologies 
leveraged together.  We created novel reporter enzymes using 
genetic fusions between highly active enzymes and an affinity 
binding motif that irreversibly binds to cellulose.  These constructs 
were inserted into phage genomes which served as sensitive 
biorecognition agents in drinking water detection assays.  The novel 
chimeric reporters specifically bound to the cellulosic filters used in 
the detection assays, allowing for low detection limits in fractions of 
the time required for standard methods. 
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PREFACE 
The work contained herein encompasses my work in creating 
recombinant bacteriophages for bacterial detection.  The 
nomenclature used for the phages described herein has changed 
from the initial names used in Chapters 2 & 3 to a more systematic 
naming convention for Chapters 4 & 5.  The final naming convention 
for recombinant phages will remain as NRGp# representing “Nugen 
Research Group phage” numbered chronologically.   
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CHAPTER 1 
FINDING A GRAPEFRUIT IN A GREAT LAKE:  
SENSITIVE DETECTION OF BACTERIA IN LARGE WATER 
SAMPLES USING BACTERIOPHAGE-BASED BIOSENSORS* 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Troy C. Hinkley, Randy Woroboro, Sam R. Nugen 
INTRODUCTION 
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While safe food and water is essential for life, millions throughout the 
world do not have reliable access to reliable sources. Clean drinking 
water is a fundamental human right essential for health and well-
being.1  Food and waterborne illnesses affect all populations and all 
demographics. The CDC estimates that in the United States alone, 
48 million people fall victim to foodborne illness each year.2 That 
statistic represents an annual cost-of-illness (medical, loss of 
productivity, mortality) of approximately $51 billion.3 The global 
foodborne illness is even more grim with an estimated 600M 
illnesses and 420,000 deaths each year.4 While clean water has 
been determined a fundamental human right, the morbidity and 
mortality associated with unsafe water is even more alarming. The 
World Health Organization estimated that in 2016, 829,000 deaths 
occurred from diarrhea as a result of poor water, sanitation and 
hygiene.   
The importance of safe water for the safety of food has been outlined 
in the Food Safety Modernization Act (FSMA) which mandates 
periodic testing of water use to irrigate and rinse produce.5  Unclean 
water has been linked to contaminated produce which represents 
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the largest share for commodities responsible for foodborne illness.6  
Improvements in the ability to rapidly detect food and waterborne 
pathogens will help reduce the burden of these illnesses. There has 
been tremendous progress in rapid detection through the 
development of improved molecular diagnostics, 
microfluidics/µTAS, and transduction methods. Additionally, there 
has been an increase in the number of research reports aiming to 
detect bacteria from food and water.7, 8 Hopefully these technologies 
will bring better assurances those in low resource settings and lower 
the incidences of these burdensome diseases. This review aims at 
helping assay developers in recognizing the true bottlenecks in 
developing rapid assays for food and water. Because many of these 
challenges are imposed by regulatory requirements, we have 
summarized many of them here. By understanding these 
requirements, developers can design their assays to fit the 
necessary constraints, in the goal of more pragmatic and deployable 
assay design for the rapid detection of bacteria in food and water. 
This critical review aims not to discourage assay developers from 
targeting food and water matrices, but inform them of the constraints 
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so that the assays developed are pragmatic and much closer to 
commercial deployment. The statistics provided earlier highlight the 
dismal situation many around the world face and provides stark 
motivation for the immediate need for rapid and reliable detection in 
bacteria food and water samples. 
WHO Guidelines 
The World Health Organization (WHO) establishes many global 
guidelines for human health and places a significant importance on 
effective sanitation of drinking water.9.  Together with the 
Organization for Economic Co-operation and Development (OECD) 
and the International Water Association (IWA), the WHO publishes 
a document titled “Guidelines for Drinking-Water Quality” as a set of 
regulatory recommendations.10, 11  These guidelines are intended to 
serve as a framework for which local governments and 
municipalities can base their individual drinking water legislation 
while still overcoming the numerous challenges present in the 
delivery of clean drinking water to the local populace.  The specifics 
of this effort are detailed in a Water Safety Plan (WSP), 
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documentation that focuses on comprehensive risk mitigation of all 
parts of the water supply, from initial collection to consumer.12, 13   
As more nations adopt the WHO guidelines into official standards, 
the design of novel devices must achieve single CFU detection to 
realize any level of efficacy in real world applications.  This review 
serves to outline the necessary goals for the design of novel 
detection devices. 
As nations where the majority of the world’s population lives 
transform the WHO international guidelines into national standards, 
the demand for detection devices capable of detecting the presence 
of a single E. coli colony forming unit (CFU) in 100 mL will only 
increase.  The WHO guidelines that are increasingly being adopted 
across the world stipulate a zero-tolerance policy for coliforms in 
drinking water.  Practically speaking, these guidelines require a 
detection device to reproducibly differentiate between the presence 
and absence of a single coliform CFU in 100 mL of drinking water.  
While this challenge is significant, the potential impact the 
implementation of clean drinking water systems is extraordinary.  
While there is still a long list of countries around the world with 
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varying requirements for microbial contamination in drinking water, 
most countries are trending towards adoption of zero tolerance 
policies.  It is extremely unlikely that a responsible legislative body 
would relax microbial contaminant standards. 
Regulatory limits 
Governments around the world have tasked regulatory agencies to 
meet the aforementioned testing requirements recommended by the 
WHO water safety guidelines.  These guidelines detail testing 
requirements with regard to frequency, performance, and bacterial 
limits. In order to establish reproducibly, these regulations set the 
limits for both bacteria concentrations and sample size. The latter is 
often the largest obstacle for rapid testing in food and water 100 mL 
of sample are typically required for water samples. For example, a 
biosensor that meets these standards must be capable of detecting 
the presence or absence of a single CFU in a 100 mL drinking water 
sample with reproducibility. 
Challenges of single CFU detection 
The physical dimensions of a single Escherichia coli cell (diameter 
0.5-1.0 um, length 1-3um) equate its volume to be approximately 
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one femtoliter or 10-12 mL.14  When that single E. coli cell is dropped 
into a 100 mL water sample, it is approximately 15 orders of 
magnitude smaller than the sample and comprises just 
0.0000000000004% of the available space.  With all things being 
equal, a standard bowling ball dropped into Lake Erie would be 
easier to find.  The motivation behind this requirement is that 
bacteria reproduce asexually through binary fission and can 
exponentially increase in biomass.  Unlike inorganic contaminants 
like mercury, arsenic, or lead, a single bacterium can quickly 
increase in concentration provided favorable environmental 
conditions.  In a relatively short period of time, a single bacterial cell 
can quickly divide into a population of many billion with most 
descendants being a near identical genetic copy of the original cell.  
If that original bacteria possessed antibiotic resistance and/or 
human virulence factors, its proliferation and persistence through 
water treatment systems presents a major public health concern. 
As a result, many legislation bodies have adopted 
presence/absence criteria for indicators microorganisms as 
recommended by the WHO15.  The rationale for this decision 
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surrounds the fact that the complete absence of bacterial 
contamination is the only way to ensure future nonproliferation of 
pathogens.   
Indicators 
In many cases, the probability of finding a pathogen, even in a 
contaminated lot, is low. Therefore, rather than searching for the 
needle in the haystack, a common approach is to identify other 
analytes which serve as indicators of contamination. The selection 
of the indicators can be controversial, as none have proven to be 
perfect. A good example is drinking water, where rather than looking 
for all of the pathogens which could be in the sample, a search for 
“generic E. coli”, which may or may not be a pathogens, could 
indicate fecal contamination, and therefore the potential of pathogen 
contamination. Similarly, Listeria spp., which contains both 
pathogenic and non-pathogenic species is a common analyte as 
opposed to searching for just the pathogenic Listeria 
monocytogenes. The presence of the genus Listeria, indicates that 
contaminating sources and growth conditions exist and that there is 
a potential of Listeria monocytogenes growth.16 From the point of 
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view of the food producer, a positive test for an indicator organism 
does not mean that there has been a positive pathogen test, which 
may require reporting to regulatory agencies.  It however, does 
mean that some form of remediation is required as the risk for 
pathogen contamination increases. Even though modifications to 
standard procedures have been developed for the specific isolation 
of pathogens,17 sampling strategies only provide a small percentage 
of final product samples.  Therefore, the presence of an indicator 
organism suggests the environmental conditions are favorable to the 
growth of bacteria and/or potential pathogens.18  The most effective 
assemblage of microbial indicators will vary based on location and 
is best determined when local and regional factors are considered19-
22.  The simultaneous evaluation of multiple indicators (including 
E.coli as recommended by WHO) provides a more complete picture 
of the water’s microbiological quality, as compared to a single 
universal indicator. 
Alternative indicator microorganisms that have shown merit include 
coliphages,23 Enterococcus,24 among others.18, 19, 25, 26 
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Viable But Not Culturable (VBNC) 
In many instances, food and water to be consumed may have 
undergone a mitigation step in order to reduce that chances of 
pathogens consumption. These methods include chlorination of 
water, pasteurization of milk, and high pressure processing of foods. 
If these foods entered their kill step with a high bacterial load, the 
final product may be free of viable bacteria, but still contain intact 
bacterial DNA. Therefore, some detection methods which rely on 
pre-enrichment and growth may result in negative results, while 
those detecting DNA might provide positive result. There is also the 
possibility of the bacteria receiving a sub-lethal injury, resulting in 
bacteria that in the short term, may not display much growth, but 
following recovery, could cause disease. Therefore, a detection 
assay aiming for rapid results may miss injured cells which in the 
short timeframe resemble non-viable cells.  However, maintaining 
clean supplies of drinking water for even small communities is non-
trivial.  Unfortunately, a visual examination of drinking water does 
not indicate the absence of pathogens.  Therefore, routine 
microbiological evaluation of drinking water supplies must be 
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performed to confirm adequate sanitation for public health.  The less 
time required for a detection assay to reach a result means more 
time for possible remediation and/or supply of clean water to thirsty 
communities. 
Bacterial Injury & Recovery 
Wastewater treatment procedures subject many indicator bacteria to 
chemical and physical processes that serve to be sublethal due to 
the cell’s stress response system.20, 29 
As a bacterial cell enters the persistor state multiple stress 
responses cause significant morphological changes to aid the cell 
navigate its new environment.  As opposed to the logarithmic cell 
growth that occurs when environmental conditions are favorable, 
bacterial cell growth almost ceases in stationary phase.  While the 
overall cell population remains relatively static, the surviving cells 
still exhibit relatively large amounts of protein production.30 
Furthermore, standard culture methods have failed to detect 
microbial indicators that have been injured through common 
disinfection techniques.31  At the higher bacterial concentrations this 
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result simply leads to an underestimation of colony counts while at 
low concentrations it produces a false negative, a significant risk.   
Detection of cells with GASP mutations 
In nature, bacteria are often starved of resources.  Even locations 
where microbial food is relatively plentiful, such as the GI tract of a 
well-fed mammal, bacterial populations experience intense 
competition from microbial rivals as they all contend for available 
resources.  As the race to convert available metabolites into biomass 
continues, nutrients are depleted exponentially as competing 
populations concurrently experience logarithmic growth.  The 
change in the cellular environment from nutrient rich to nutrient poor 
triggers a cascade of changes to the cell’s proteome.  The increased 
expression of stress related sigma factors (rpoS) further promotes 
the production of proteins uniquely suited for stressful environments.  
If nutrients remain sparse over an extended period of time, cells 
expressing the Growth Advantage in Stationary Phase (GASP) 
phenotype will dominate the population as the nutrient scarcity 
creates a strong selection factor for which they are uniquely suited.  
When bacterial cells do not have the proper environmental 
 22 
conditions for growth they enter a stationary state where most cells 
die (~99%) and cell division essentially terminates for the survivors.  
It has been shown that less than a week is required for the original 
bacterial population to become dominated with GASP cells better 
suited for their new desolate environment. 32  It has been shown that 
upregulation of the rpoS sigma factor causes a regulatory shift 
toward the favored expression of stationary phase genes in E. coli 
33, 34. 
Furthermore, E. coli has been shown to maintain plasmid DNA even 
in the absence of selection.35  These extrachromosomal DNA 
elements often provide the cell with new capabilities (virulence 
factors, antibiotic resistance, etc.) but at the cost of valuable cellular 
resources. Detection methodologies must take into consideration 
the myriad of outcomes possible when cells exhibit the GASP  
phenotype common to injured but not killed bacterial cells.   
CONCLUSION 
Incredible improvements have been made globally regarding clean 
drinking water, with the achievement of the millennium development 
goal 5 years early in 2010.27  However, many are still forced to go to 
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great lengths to obtain drinking water without any promise that the 
water will be free of pathogens.  Furthermore, the ingestion of 
drinking water that appears perfectly safe to drink may still cause 
significant disease due to the small infectious doses of some 
pathogens28.  Therefore, rapid analysis of drinking water for 
microbial contaminants is critical to maintain public health.   
While water is a common analyte for those developing biosensors, 
it should be noted that detecting bacteria in water presents many 
more challenges due to practical considerations. Technologies 
such as lab-on-a-chip has shown tremendous promise in many 
fields. But if drinking water is selected as a matrix, the challenge of 
sample size (100 mL) makes miniaturized systems difficult. 
Similarly, the push for rapid diagnostics has led many to investigate 
real-time or near real-time assays. This is met with the problem of 
the need to differentiate viable, non-viable and injured cells. In 
order to perform these differentiations, sufficient recovery time 
must be given to injured bacteria to enable them to be identified as 
viable vs. non-viable. These processes are biological in nature and 
difficult to accelerate. Most biosensors for the detection of bacteria 
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in water samples often need to compromise on some of the current 
requirements set forth by regulatory agencies. A rapid test (~1-5 
hours) which can confidently detect 1 CFU/ 100 mL of viable or 
sub-lethally injured E. coli in drinking water, using minimal 
equipment, and at low-cost, has not yet been developed. 
Therefore, while many biosensor developers may consider drinking 
water to be the “low hanging fruit” of matrices, the constraints that 
go with it places pragmatic biosensors for bacteria detection out of 
reach.  
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CHAPTER 2 
GENETIC OPTIMZATION OF A PHAGE-DELIVERED ALKALINE 
PHOSPHATASE REPORTER TO DETECT ESCHERICHIA COLI* 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Troy C. Hinkley1, Angelyca A. Jackson1 Joey N. Talbert, Sam R. 
Nugen1,2, and David A. Sela1,2,3 
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ABSTRACT 
A large fraction of foodborne illnesses are linked to (∼46%) leafy 
green vegetables contaminated by pathogens harbored in 
agricultural water. To prevent this, accurate point-of-production 
detection tools are required to identify and quantify bacterial 
contaminants in produce before consumers are impacted. In this 
study, a proof-of-concept model was engineered for a phage-based 
Escherichia coli detection system. We engineered the coliphage T7 
to express alkaline phosphatase (ALP) to serve as the signal for E. 
coli detection. Wild type phoA (T7ALP) and a dominant-active allele, 
phoA D153G D330N (T7ALP*) was inserted into the T7 genome, with 
engineered constructs selected by CRISPR-mediated cleavage of 
un- altered chromosomes and confirmed by PCR. Engineered 
phages and E. coli target cells were co-incubated for 16 hours to 
produce lysates with liberated ALP correlated with input cell 
concentrations. A colorimetric assay used p-nitrophenyl phosphate 
(pNPP) to demonstrate significant ALP production by T7ALP and 
T7ALP* compared to the vector control (T7EV) (p ≤ 0.05). Furthermore, 
T7ALP* produced 2.5-fold more signal than T7ALP (p ≤ 0.05) at pH 10. 
 32 
Due to the increase in signal for the modified ALP* allele, we 
assessed T7ALP* sensitivity in a dose-responsive manner. We 
observed 3-fold higher signal for target cell populations as low as ∼2 
× 105 CFU mL−1 (p ≤ 0.05 vs. no-phage control). 
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INTRODUCTION 
Foodborne pathogens cause significant human suffering and their 
effects potentially extend to loss of life. The United States Center for 
Disease Control estimates that there are 9.4 million incidences of 
foodborne illness in the U.S. with approximately 56 000 
hospitalizations each year.1,2 Approximately 46% of these cases of 
foodborne disease are linked to leafy green vegetables,3 which are 
often contaminated from soiled rinse or irrigation water and other 
poor agricultural practices. In order to reduce the incidence of 
diarrheal morbidity and mortality and address the considerable 
public health burden attributed to foodborne pathogens, next 
generation rapid detection innovations are sought to identify 
contaminated foods prior to distribution and consumption. 
Currently, portable detection technologies target bacterial 
pathogens such as Escherichia coli, Salmonella spp., 
Campylobacter jejuni, and Listeria spp. using antibodies that interact 
with taxon-specific cell surface epitopes.4 Whereas antibodies 
efficiently detect target microbes, these platforms are often 
financially restrictive, unstable, and may require a suboptimal 
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timeline to identify threats to food systems. In contrast, 
bacteriophage or phage-based detection platforms can be produced 
cheaply and often produce expedient results.5 
Phages are viruses that prey on bacteria and commandeer their 
fundamental cellular processes in order to replicate. Due to a 
restricted host range in which phages infect specific targets, phage–
host interactions could be exploited to serve as a biological probe to 
provide rapid and specific pathogen recognition.6 Phage-based 
detection platforms commonly utilize genetically engineered phages 
that encode reporter proteins to be expressed in their targeted hosts 
in order to amplify what would be a weak detection signal.7,8 These 
reporter proteins include firefly luciferase,9 green fluorescent 
protein,10 tobacco etch virus protease,11 and alkaline phosphatase 
(ALP; EC 3.1.3.1).11 For the latter marker, there are several sensitive 
mechanisms for alkaline phosphatase detection: colorimetric,12 
fluorescent,13 chemiluminescent,14 and electrochemical.15 Here we 
report modification of bacteriophage T7, a double-stranded DNA 
virus with a broad-host range in E. coli,16 as a vector that 
overexpresses ALP upon infection of its target. 
 35 
MATERIALS & METHODS 
Bacterial strains and growth conditions 
Bacteria and bacteriophage strains used in this study are listed in 
Table 1. Bacterial strains were propagated in lysogeny broth (10 g 
tryptone, 5 g yeast extract, 5 g NaCl, and 15 g agar when 
appropriate) and supplemented with ampicillin (100 μg mL−1), 
kanamycin (50 μg mL−1), chloramphenicol (35 μg mL−1), and/or 
streptomycin (50 μg mL−1) as needed. Cultures were grown 
aerobically at 37 °C and on an orbital shaker (225 rpm) for broth 
cultures. 
ALP-encoding constructs 
The three ALP constructs that were engineered within T7 were 
obtained through direct synthesis (GenScript, Piscataway, NJ).  
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Table 1 Strain and plasmid list  
 ID Source 
Bacteria and bacteriophage   
 Escherichia coli DH5α Invitrogen 
 Escherichia coli JM109 Promega 
 Escherichia coli BL21 Invitrogen 
 Escherichia coli BL21 pWUR397, 
pWUR400, pWUR477-anti-T7 This study 
 Escherichia coli O6 ATCC 25922 
 Escherichia coliO157:H7 ATCC 43890 
 Escherichia coliO157:H16 PSU 750140 
 Escherichia coliO2:H7 PSU 880592 
 Escherichia coliO26:H11 CDC 3047-86 
 Bacteriophage T7 wild type ATCC BAA-1025-B2 
 T7EV; empty vector in class 1 region This study 
 T7ALP; phoA with C-term 6× HIS tag 
in class 1 region This study 
 T7ALP*; phoA D153G D330N with 
HIS tag This study 
Plasmids     
 pBAD18 17 
 pEV; pBAD18 + T7 expression 
construct (T7EC) This study 
 pALP; pEV with wild type phoA in 
T7EC This study 
 pALP*; pEV with phoA D153G 
D330Nin T7EC This study 
 pWUR397 18 
 pWUR400 18 
 pWUR477 18 
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 pWUR477-anti-T7; pWUR477 with 
T7 targeting spacer This study 
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This includes a construct that does not contain ALP referred to as 
the empty vector (pEV), a construct that incorporates the E. coli 
BL21 (Thermo Fischer, Waltham, MA) ALP gene (phoA) with a C-
terminal polyhistidine (6×) affinity purification tag referred to as 
(pALP), and a construct with a modified variant of phoA that 
expresses two amino acid substitutions (i.e. D153G and D330N) 
referred to as (pALP*).  In order to insert the constructs into the 
phage genome via homologous recombination, we placed the 
synthetic genes into a plasmid backbone (pBAD18-Amp.17). The 
inserts were amplified with the following primers: For- 
ACCCGTTTTTTTGGGCTTGTTACTTAGCGGCAGTGTG. Rev-
CTA- GAGGATCCCCGGGGAGCGCAAGGCATCCTA). The PCR 
product was ligated into NheI-HF and KpnI-HF digested pBAD18-
Amp using the In-Fusion HD Cloning Kit (Clontech Laboratories, Inc, 
Mountain View, CA). Ligated vectors were transformed into Clontech 
Stellar chemically competent cells with transfor- mants selected on 
LB with ampicillin. Transformants were screened by purifying 
plasmids with the QIAprep Spin Mini- prep kit (Qiagen, Valencia, 
California), and confirmed via PCR and DNA sequencing. 
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Phage-based detection platform engineering 
Generation of crude phage lysates. To produce T7 phage with the 
EV (T7EV), ALP (T7ALP), or ALP* (T7ALP*) insert, 1.0 × 108 plaque 
forming units (PFU) mL−1 of T7 phage were added to exponentially 
growing E. coli BL21 containing the plasmids pEV, pALP, and 
pALP*. Co-incubation proceeded overnight (16 h) at 37 °C to allow 
lysis to occur. The co-cultures were then centrifuged at 13 000 rpm 
for 10 minutes and filter steri- lized (0.45 μM) (Millex; EMD Millipore, 
Billerica, MA). 
CRISPR-based selection of mutant phage. We selected for 
mutant phages by adapting a previously published protocol to modify 
the T7 genome.8 This method exploits the type I-E CRISPR-Cas 
system18 to preferentially digest non-edited genomes as directed by 
spacers encoding the native genome sequence. The native spacer 
for T7 phages was generated by PCR amplification of plasmid 
pWUR477 that contains proto- spacers while adding 31 bp 
sequences from the class 1 T7 locus to target this site (FWD-
GGAGGTACACACCA- 
TGGAGTTCCCCGCGCCAGCGGGGATAAACCGCAGCCGAAGC
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C- AAAGAATTC REV-
TTTAGTGAGTCGTATTCGGTTTATCCCCGCT- 
GGCGCGGGGAACTCTCTAAAAGTATACATTTGTT). The PCR 
product was phosphorylated (T4 Polynucleotide Kinase, NEB), self-
ligated, and chemically transformed into E. coli BL21 com- petent 
cells. The companion CRISPR-encoding plasmids pWUR397 and 
pWUR400 were co-transformed resulting in a BL21 derivative that 
cleaves unmodified T7 following infection (BL21 anti-T7). A plaque 
assay was performed with 100 μL of crude lysate from “Generation 
of crude phage lysates” was mixed in molten top agar (0.8%) with 
BL21 anti-T7 and spread on pre-warmed LB plates. Following 
overnight incubation at 37 °C, plaques were counted and assessed 
for their size. Plaques larger than 0.4 cm were screened by PCR 
using primers specific for the expression construct FWD-
ACCCGTTTTTTTGGGCTTGTTACTTAGCGGCAGTGTG Rev- 
CTAGAGGATCCCCGGGGAGCGCAAGGCATCCTA. 
Alkaline phosphatase assay 
BL21 anti-T7 was propagated in LB + Cm/Kan/Str overnight at 37°C 
and subcultured at OD600 nm 0.05 to exponential phase (∼3 h). 
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Cultures were infected with the indicated phage and were co-
incubated until lysis of bacterial culture. Lysates were centrifuged at 
13 000 rpm for 10 minutes and filter sterilized (0.45 μM) (Millex). 
Lysates were adjusted to pH 8.2 (T7EV and T7ALP), or pH 10.0 (T7ALP*) 
with NaOH and supplemented with 1 mM MgCl2 in order to detect 
optimal activity.19 To measure ALP activity, lysates from T7EV, T7ALP, 
and T7ALP* co-cultures were incubated with p-nitrophenyl phospate 
(pNPP, NEB) as a colorimetric indicator using a method adapted as 
described previously.19 Colorless pNPP was hydrolyzed to yellow p-
nitro- phenol (pNP) in the presence of ALP and was quantified at 
405 nm (molar extinction coefficient 1.62 × 104 M−1 cm−1).19–21 25 μL 
of the lysate was added to an equal volume of 50 mM pNPP and 
monitored for 60 minutes in a 96-well microplate fluorometer 
(BioTek; Synergy H4) according to the instructions of the 
manufacturer. pNP release was measured by the change in 
absorbance at 405 nm at 37°C. Assay calibration was performed 
evaluating serial dilutions of p-nitrophenol in lysogeny broth to 
generate a standard curve. 
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Dose response assay 
Overnight cultures of E. coli strains were serially diluted 10-fold to 
produce 108 to 105 CFU mL−1 solutions. Aliquots of 10 μL from each 
dilution were plated to determine cell density. Subsequently, the 
target cell dilutions were inoculated with 1 × 107 PFU mL−1 T7ALP* 
and co-incubated at 37 °C for 16 h. pNP formation was assayed as 
described. As a control, the T7ALP* susceptible strains were serially 
diluted in sterile water. 
T7ALP* host range 
The E. coli strains listed in Table 1 were propagated overnight in LB 
at 37 °C with 200 rpm shaking. An aliquot (100 μL) of overnight 
culture was co-incubated with 1 × 107 PFU mL−1 T7ALP* in fresh LB 
broth to determine the infectivity profile of the recombinant phage. 
pNP conversion was measured in positive strains in a dose response 
manner as described. 
ALP purification 
HisPurTM Cobalt Resin Purification columns (ThermoFisher 
Scientific) were used to purify the ALP expressed from the 
engineered bacteriophage. The recombinant enzymes T7ALP & 
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T7ALP* both contain a 6× poly-histidine residue that selectively binds 
to a cobalt-charged chelator immobilized onto a 6% agarose 
crosslinked resin. A protease inhibitor was added to the phage lysate 
applied to the column and all purification steps were performed on 
ice or at 4°C. Wash and elution buffers both contained 300 mM 
sodium chloride and 50 mM sodium phosphate buffer, pH adjusted 
to 7.4. Elution was facilitated with imidazole, which exhibits stronger 
binding affinities to the cobalt chelators than the poly-histidine tags. 
The wash buffer contained 10 mM imidazole to displace non- 
specifically bound proteins whereas the elution buffer releases the 
bound proteins from the column with 150 mM imidazole. However, 
the concentration of imidazole in the elution buffer is high enough to 
strongly inhibit alkaline phosphatase22 and must be removed from 
solution prior to pNPP activity assays. Zeba Spin Desalting Columns 
(ThermoFisher Scientific) were used to remove the excess imidazole 
by employing a size exclusion resin with a molecular weight cut-off 
at 20 kDa. The samples were dialyzed against a storage solution 
containing 20 mM Tris-HCl (pH 8.2), 10 mM MgCl2 as a cofactor, 
and 0.02% (w/v) NaN3. Long term storage of the purified enzyme 
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was done at −20°C in a 50% glycerol/storage buffer solution to 
minimize solvent crystallization. 
Enzyme quantification 
The total concentration of purified enzyme was determined by the 
Micro-Bradford assay (Thermo Scientific) in which 150 μL of a 10% 
purified alkaline phosphatase sample was introduced to 150 μL BCA 
working reagent in a 96-well microplate and shaken continuously at 
37 °C for 120 minutes. The dynamic range of the Micro-Bradford 
assay has been reported to be 0.5–20 μg mL−1.23 Absorbance values 
at 562 nm were measured using a 96-well microplate fluorometer 
(BioTek; Synergy H4) and compared to a calibration curve produced 
from bovine serum albumin (0.4–200 μg mL−1 BSA). 
Enzyme kinetics 
The purified alkaline phosphatase enzyme samples were subjected 
to biochemical characterization at 37°C by measuring p-nitrophenol 
production every 60 seconds at 405 nm. Varying concentrations of 
substrate (0.25 mM–100 mM pNPP) were used to elucidate the Kcat 
and Km values from Michaelis–Menten enzyme kinetics where 
saturation occurs for both the enzyme (100 mM pNPP) and the 
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substrate (0.25 mM pNPP). At a constant enzyme concentration, the 
rate of reaction products (μmol pNP s−1) was plotted with respect to 
substrate concentration (mM pNPP). One unit of alkaline 
phosphatase activity was defined as the concentration required to 
produce 1 μmol of p-nitrophenol in 60 seconds. Non-linear curve 
fitting was employed to calculate Km and Kcat values for the 
respective wild type and mutant alkaline phosphatase enzymes. 
General statistics 
Biological triplicates were averaged for the alkaline phosphatase 
assays. Resultant means were compared in a two-sample t-test 
assuming equal sizes but unequal variance. Significant differences 
were reported as p ≤ 0.05. 
RESULTS 
In order to engineer T7 to produce a heterologous reporter protein, 
we designed several gene expression constructs that were inserted 
into the T7 genome in the class 1 region. Because genes in this 
region are expressed before those in class 2 or 3,24 we predicted 
that expression of the reporter would be higher in this region. Fig. 1 
depicts the features of the expression construct in the absence of 
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the E. coli ALP gene (i.e. phoA insert). The empty vector construct 
lacks phoA and serves as the negative control for subsequent ALP 
expression assays. The sequence of the control construct and 
experimental constructs is provided in the appendix.  The construct 
was engineered to incorporate gp1.2 from bacteriophage T3 (ATCC 
11303-B3) and a multiple cloning site (MCS) with seven  
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Figure 1. T7 Expression Construct Design. Depicted is the control 
construct, pEV. It features (1) Bacteriophage T3 gp1.2 under control 
of the T7 promoter, ribosome binding site (RBS), and terminator from 
pET-3a (EMD Millipore). (2) An MCS sequence with 7 unique single-
cutter restriction sites (XhoI, BamHI, DpnII, BstEII, NotI, EagI, ApaI) 
under the control of the T7 promoter, RBS, and terminator. The 
construct is flanked by 66 bp segments of the T7 genome. pALP and 
pALP* have phoA and phoA D153G D330N inserted into the MCS. 
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unique restriction sites under the control of the T7 promoter, 
ribosome binding site (RBS), and terminator. Our previous work 
demonstrated that these promoter and RBS sequences enables 
efficient overexpression of downstream genes in T7.25 The construct 
is flanked by 5′ and 3′ regions of homology to the class I region of 
the T7 genome to facilitate homologous recombination. The gp1.2 
gene enables bacteriophage T3 to successfully infect F-plasmid 
containing E. coli, thus broadening the host-range of the T7 
detection platform.26 
In order for the infecting phage to express ALP, wild type phoA (ALP) 
and a dominant-active allele, phoA D153G/D330N (ALP*)19 were 
inserted into the MCS site. The variant allele encodes for a protein 
that maintains conformation and stability.27 Use of the dominant-
active allele was preferable because ALP* activity was previously 
demonstrated to be stronger with these two amino acid 
substitutions.19 Therefore, we investigated the potential for the ALP* 
allele to provide elevated activity in a phage-based detection 
scheme. 
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Accordingly, these constructs were synthesized and cloned into an 
E. coli expression vector.17 As designed, engineered phages were 
generated in a series of propagations on target cells containing anti-
native T7 CRISPR plasmids (i.e. BL21 anti-T7) as detailed in 
materials and methods. Candidate phage vectors were confirmed by 
PCR before ALP detection assays were performed. 
Production of alkaline phosphatase by engineered T7 strains 
To characterize the capacity of the engineered phage to detect E. 
coli, the concentration of ALP produced following infection was 
assessed. Exponentially growing target E. coli cells were incubated 
at 2.0 × 108 CFU mL−1 with the three engineered phages: T7EV, T7AP, 
and T7ALP*. We assayed media alone and the T7EV as controls to 
ascertain background ALP phosphatase activity. Lysates were 
collected after 16 hours of co-incubation, and analyzed for ALP 
activity based on pNPP hydrolysis. 
We assayed pNP production after 10 minutes and observed 
insignificant basal ALP expression in lysates generated with T7EV 
(Fig. 2).  
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Figure 2. Alkaline Phosphatase is expressed in engineered T7 
phage. Engineered T7 phage were co-incubated for 16 h at 37˚C to 
generate lysates. Lysates were measured for ALP production by the 
hydrolysis of 50 mM pNPP in 30 minutes. Data was read over time 
at OD405 nm. The data are the means of three biological replicates. 
*, P ≤ 0.05 compared to empty vector control 
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This low level (1.4 × 10−4) of ALP activity may be attributed to 
constitutive expression within the E. coli target strain. However the 
T7ALP phage promoted a 5.5-fold increase in pNP signal over 
baseline (p = 0.08). Whereas the native E. coli ALP protein (i.e. 
PhoA) is active at pH 8.0, the ALP* variant is most active at pH 10.0 
(ref. 19) thus assays were conducted at this optimal alkaline 
environment. Interestingly, T7ALP* provided 15-fold more signal 
compared to basal conditions with T7EV (p < 0.02), and 2.7-fold more 
signal than the wild type ALP allele (p < 0.05). These data 
demonstrate successful engineering of the T7 genome as well as a 
clear improvement in signal production by the modified ALP* allele. 
Biochemical characterization of ALP & ALP* purified enzymes 
To characterize the differential rates by which ALP and ALP* 
hydrolyzes substrate, both recombinant proteins were purified to 
have their kinetics evaluated. These HIS-tagged proteins were 
purified from a cobalt-column prior to determining concentrations. 
The enzymatic kinetics was determined using a range of substrate 
concentrations (100 mM–0.25 mM) that allowed for full saturation of 
substrate (100 mM pNPP) and full saturation of enzyme (0.25 mM 
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pNPP). The turnover number (Kcat) was determined by normalizing 
the Vmax value to the concentration of enzyme present. As a result, 
Kcat was calculated to be 30s−1 for the wild type enzyme and 1344s−1 
for the D153G/D330N double mutant. Km corresponds to the 
substrate concentration at which the reaction rate is half of its 
maximum and was calculated to be 14.2 μM for the native ALP and 
354.1 μM for the modified ALP* allele. The catalytic efficiency of 2.1 
for ALP and 3.8 for ALP* was evaluated by taking the ratio of Kcat : 
Km to describe the efficiency pNPP hydrolysis. 
ALP intensity is dependent on target cell density 
As T7ALP* provided the strongest signal intensity, this vector was 
used for determining the optimal density of target cells with a dose–
response assay. E. coli BL21 cells that had achieved mid- 
exponential growth were serially diluted 10-fold with 1 × 109 PFU 
mL−1 T7ALP* added and co-incubated for 16 h. Fig. 3 depicts the 
range of target bacterial densities were detected using T7ALP*. 
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Figure 3. ALP activity signal increases in a dose-dependent 
manner. T7ALP* was co-incubated with varying concentrations of E. 
coli BL21 until culture lysis. ALP expression was measured by the 
hydrolysis of 50 mM pNPP in 60 mins. A culture without T7ALP* 
served as the base-line control. The data are the means of three 
biological replicates. *, P ≤ 0.05 (compared to empty vector control).  
 
0
0.002
0.004
0.006
0.008
0.01
0.012
Bacteria only 1.80E+05 1.80E+06 1.80E+07 1.80E+08
pN
PP
 tu
rn
ov
er
 (O
D
 4
05
 n
m
)
Bacterial Cells
 54 
 A positive signal was obtained above background for 1.8 × 105 CFU 
mL−1 (p < 0.05). In addition, we observed an increase in signal 
(∼2.5-fold) coinciding with increased target cell density. These data 
indicate that the sensitivity for T7ALP* is ∼1 × 105 CFU mL−1 under 
proof-of-principle conditions. 
E. coli host range of the engineered T7ALP* phage 
In order to determine the host range breadth of the recombinant 
phage, E. coli strains were co-incubated with a high titer LB solution 
of T7ALP* (Table 1). Cell lysis was observed in the three laboratory 
strains (i.e. BL21, DH5α, and JM109) and did not occur in the strains 
possessing the O or H antigens tested. The limit of detection (i.e. 
positive signals above background) for DH5α and JM109 were 6.5 
× 105 CFU mL−1 and 5.4 × 105 CFU mL−1 respectively. No significant 
differences in detection limits were observed when dilutions were 
performed in sterile water as opposed to LB (data not shown). 
 
 
DISCUSSION 
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We have developed an effective model to modify broad-host range 
bacteriophages to express heterologous reporters. The engineered 
phage successfully delivered the reporter protein to target cells to 
enable E. coli detection. Furthermore, the signal intensity following 
modification of the ALP gene to generate the T7ALP* phage 
represents a significant improvement (2.6- fold, p < 0.05) than that 
of the wild type allele. We have demonstrated that the engineered 
ALP* is ∼45 fold more active than the wild type ALP, in close 
agreement with previous work. 
In addition, this 45-fold increase in alkaline phosphatase activity in 
assays of purified ALP D153G/D330N protein in the absence of cell 
debris. This is likely due to assessing purified enzyme activity rather 
than expression within the complex biochemical environment of a 
lysate. Moreover, increasing the concentration of divalent cations 
may improve phage adsorption and could potentially improve ALP* 
intensity, thus providing another opportunity to optimize this 
detection platform.28 Affinity purification and subsequent kinetic 
characterizations of the enzymes in the absence of cell debris 
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provided a method to accurately compare the activity of different 
enzymes. 
Previously, the two amino acid substitutions to the ALP* catalytic 
pocket yielded a highly active, thermo-resistant enzyme similar to 
bovine ALP in purified assays.19 This is due to the higher turnover 
number (kcat) of this “mammalianized” alkaline phosphatase along 
with a stronger substrate affinity (Km).29 This represents a significant 
improvement for the T7ALP* vector to be applied as a preferred on-
farm diagnostic. Second, the variant ALP* previously exhibited the 
ability to maintain activity after extended storage period of 1 year.19 
This suggests that it is recalcitrant to environ- mental challenges that 
would inactivate antibody-based detection schemes. 
Genetic manipulation of the T7 phage did not modify structural 
components that may interfere with host cell binding (e.g. tail fibers). 
As such, and consistent with previous results,30 T7ALP* did not 
infect all E. coli serotypes tested in this study. Future applications 
may necessitate deploying several phages simultaneously to cover 
the broadest possible host range.31 
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E. coli BL21 was detected at a concentration of 1.8 × 105 CFU mL−1 
following 16 hours of co-incubation. This limit of detection was 
comparable to other strains tested (i.e. DH5α, JM109). A lower 
detection limit of detection could be conceivably achieved with 
further assay optimization. 
CONCLUSION 
This phage-based system represents a facile template to innovate 
analogous platforms to detect and quantify bacterial pathogens in 
food systems, clinical settings, and the environment. This is 
consistent with future goals of rapidly engineering multiple detection 
platforms in parallel to address emerging bacterial threats. Phage 
propagation can be accom-plished relatively quickly, making it much 
more cost- and time-effective than raising antibodies. Thus, this 
approach could be extended towards pathogenic threats by 
modifying cognate phages including Salmonella, Listeria, and 
Campylobacter.32–34 Together these data demonstrate that the 
bioengineered phage-based detection platform is a viable alternative 
to current bacterial detection systems. 
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CHAPTER 3 
THE REPORTER BACTERIOPHAGE T7NLC UTILIZES A NOVEL 
NANOLUC::CBM FUSION FOR THE ULTRASENSITIVE 
DETECTION OF ESCHERICHIA COLI IN WATER* 
 
 
 
 
 
 
 
 
 
 
 
 
* T. C. Hinkley, S. Singh, S.Garing, A-L. M. Le Ny, K. P. Nichols, J. 
E. Peters, J. N. Talbert, and S. R. Nugen 
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ABSTRACT 
Rapid detection of bacteria responsible for foodborne diseases is a 
growing necessity for public health. Reporter bacteriophages 
(phages) are robust biorecognition elements uniquely suited for the 
rapid and sensitive detection of bacterial species. The advantages 
of phages include their host specificity, ability to distinguish viable 
and non-viable cells, low cost, and ease of genetic engineering. 
Upon infection with reporter phages, target bacteria express reporter 
enzymes encoded within the phage genome. In this study, the T7 
coliphage was genetically engineered to express the newly 
developed luceriferase, NanoLuc (NLuc), as an indicator of bacterial 
contamination. While several genetic approaches were employed to 
optimize reporter enzyme expression, the novel achievement of this 
work was the successful fusion of the NanoLuc reporter to a 
carbohydrate binding module (CBM) with specificity to crystalline 
cellulose. This novel chimeric reporter (nluc::cbm) bestows the 
specific and irreversible immobilization of NanoLuc onto a low-cost, 
widely available crystalline cellulosic substrate. We have shown the 
possibility of detecting the immobilized fusion protein in a filter plate 
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which resulted from a single CFU of E. coli. We then demonstrated 
that microcrystalline cellulose can be used to concentrate the fusion 
reporter from 100 mL water samples allowing a limit of detection of 
<10 CFU mL−1E. coli in 3 hours. Therefore, we conclude that our 
phage-based detection assay displays significant aptitude as a 
proof-of-concept drinking water diagnostic assay for the low-cost, 
rapid and sensitive detection of E. coli. Additional improvements in 
the capture efficiency of the phage-based fusion reporter should 
allow a limit of detection of <10 CFU per 100 mL. 
 66 
INTRODUCTION 
Drinking water contaminated with pathogenic bacteria is a major 
public health concern, both in the United States1–4 and worldwide.5 
Escherichia coli (E. coli) is a major cause of global morbidity and 
mortality. While the WHO estimates approximately 63,000 annual 
deaths are due to foodborne E. coli infections, there is an added 
consequence of 5 million years of life lost (YLLS) and 5 million 
disability adjusted life years (DALYS).5 In addition to gastrointestinal 
infections, E. coli is the most common causative agent for urinary 
tract infections, 8.9% of sepsis cases, and 29% of early onset 
neonatal sepsis cases.6,7 “Generic” E. coli is often used as an 
indicator for contamination or improper sanitation of water or food.8,9 
Found in high concentrations in the feces of most mammals, the 
presence of E. coli is considered the best biological indicator for fecal 
contamination in drinking water.10 
While the identification of indicators or potential pathogens often 
involves the culturing of serological, food, or environmental samples, 
new technologies have been introduced with the promise of bringing 
assay times from days, to hours, and even minutes. While some of 
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these advanced technologies (e.g. optical nanostructures, surface 
enhanced Raman spectroscopy) have shown promise as sensitive 
detection methods, these methods typically require a relatively clean 
sample in a small volume. It is clear that the true bottleneck to rapid 
detection remains with the separation, concentration, and cleanup 
steps of the initial sample preparation. An ideal separation method 
should (1) remove the analyte from the matrix, (2) remove any 
possible inhibitors to a downstream detection system, and (3) 
reduce the sample size while maintaining a high capture efficiency.11 
Unfortunately, there does not presently exist a pragmatic system 
that integrates sample preparation and pathogen detection from 
large volume samples. While the vast majority of research focuses 
on improving the sensitivity of pathogen detection rather than 
separation/concentration, an ideal detection platform would 
incorporate all these components as well as the ability to determine 
cell viability. 
Furthermore, bacterial species causing foodborne disease have 
been shown to rapidly gain virulence factors as well as antibiotic 
resistance markers, further necessitating the need for rapid 
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detection methods to successfully mitigate the population's 
exposure to potentially harmful pathogens. The increasing 
prevalence of E. coli strains that are resistant to all known antibiotics 
is considered one of the most serious risks to public health in the 
near future.12 This relatively rapid rise of antibiotic resistance in 
pathogens has been confirmed and is actively monitored by the 
Centers for Disease Control (CDC) and the National Antimicrobial 
Resistance Monitoring System (NARMS).13,14 
Bacteriophage (phage) based detection methods have 
demonstrated a high potential to detect, mitigate and control the 
causative bacterial agents of foodborne illness.15–21 Phages are a 
natural viral predator of bacteria whose total population outnumbers 
any other biological entity on the planet.22 Infection begins with 
binding to host cell surface receptors and then injecting their genome 
into the cell through specific and localized degradation of the 
bacterial cell wall.23 This highly specific and irreversible interaction 
is the first major determinant of a phage's range of potential hosts. 
While other genetic factors contribute to a phage's ability to infect a 
host (restriction enzymes, CRISPR, etc.), directed genetic 
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modifications to phage tail components involved in the initial binding 
event have successfully expanded the host range.24 
Upon infection, the injected phage DNA has been shown to 
dramatically alter bacterial gene expression and metabolism. For 
example, some phages encode factors that alter the promoter 
specificity of the host RNA polymerase to selectively force 
overexpression of phage DNA.25 Furthermore, other phages have 
been shown to cause the complete cessation of bacterial 
macromolecular synthesis, allowing for the specialized allocation of 
cellular resources for phage expression and reproduction.26 
Reporter phages are created when an exogenous gene is added to 
a phage genome, causing expression of a readily detectable 
enzyme concurrent with phage infection.19 The concentration of 
enzyme in solution can be correlated with the susceptible bacterial 
population within the sample. Commonly used phage reporters 
include alkaline phosphatase (phoA),27–29 beta-galactosidase 
(lacZ),28,30,31 green fluorescent protein (gfp),32,33 and bacterial 
luciferases (luxAB or luxCDABE),34–36 among others.23,37,38 
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Recently engineered and commercialized by Promega, a highly 
active luciferase (NanoLuc or NLuc) and substrate (furimazine) 
system have generated luminescent signals orders of magnitude 
greater than that of other commonly used luciferases.39 
Furthermore, the small size of NanoLuc (19 kDa), coupled with its 
high activity, makes it an ideal candidate for a phage reporter where 
any genetic insertion must be small enough to fit the expanded 
genome into the phage capsid.40,41 
In order to concentrate and purify engineered proteins, numerous 
epitope tags such as His-tag,42 AviTag,43 and FLAG,44 among 
others45 are commonly used. These tags bind to cobalt,46 biotin,43 
and/or antibody substrates, respectively, all of which are expensive, 
complex or both. The type of affinity tag used in this work, a 
Carbohydrate Binding Module (CBM), has been widely employed as 
protein fusions47 to provide immobilization onto low-cost, widely 
available substrates. Carbohydrate binding modules are commonly 
found within carbohydrate active enzymes that fold independently of 
the larger protein structure and display specific binding to 
carbohydrate substrates.47 The specific ligand used in this work 
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(CBM2a from Cellulomonas fimi) displayed irreversible binding to 
crystalline cellulose when expressed as a fusion protein.48 A CBM is 
a crucial component of many carbohydrate active enzymes, 
especially for insoluble substrates where enzyme diffusion would 
limit substrate availability. 
In this paper, we present a novel recombinant phage that has been 
constructed and implemented into a detection system capable of 
detecting low concentrations of viable E. coli cells. The novel fusion 
reporter phage T7NLC employs the highly active NLuc luciferase 
fused to the irreversibly binding carbohydrate binding module 
CBM2a to sensitively detect E. coli cells in drinking water samples. 
While a cocktail of phages may be required for the detection of an 
entire bacterial species, we targeted E. coli BL21 as a proof-of-
principle model to demonstrate the potential sensitivity of our 
system. 
This work outlines the successful (i) modification of the T7 phage 
genome to contain nluc or nluc::cbm reporter genes, (ii) expression 
of NanoLuc or NanoLuc::CBM in E. coli from infection of T7NL or 
T7NLC, respectively, (iii) estimation of E. coli concentration required 
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to generate a detectable signal, and (iv) demonstration of a low-cost 
and rapid method to detect E. coli in 100 mL of drinking water using 
a phage-based detection strategy. 
MATERIALS & METHODS 
Materials 
Unless otherwise noted, all chemicals were reagent grade and 
purchased from Fisher Scientific (Pittsburgh, PA, USA) or Sigma-
Aldrich (St Louis, MO, USA). DNA synthesis was provided by 
Integrated DNA Technologies (Coralville, Iowa, USA). Restriction 
enzymes and DNA polymerases were purchased from New England 
Biolabs (Ipswitch, MA, USA). Escherichia coli BL21 (ATCC® BAA-
1025TM) and E. coli Castellani and Chalmers (ATCC 13706), 
routinely used in this study as hosts for phage T7, were grown 
aerobically in Luria Bertani (LB) at 37 °C with continuous shaking 
agitation. Transformation of recombinant phage DNA was performed 
in electrocompetent E. coli DH10B cells (MegaX, Invitrogen, USA). 
Genomic phage DNA to be used as a cloning vector was purified 
from T7Select 415–1 (Novagen, USA) propagated in BL21. 
Extraction of phage DNA was performed with the Qiagen Genomic 
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Tip 100/G (Qiagen, Hilden, Germany) according to the 
manufacturer's instructions. Routine DNA purifications were 
performed using glycogen for nucleation and precipitated using 
sodium acetate (3 M) and ethanol (100%).49 
Phage stock preparation 
An overnight E. coli BL21 culture (2 mL) was added to LB media 
(200 mL) and incubated (37 °C, 250 rpm, 2–3 hours) until an OD600 
of 0.4–0.6, suggesting steady state growth.50 Recombinant T7 
phage was added at a multiplicity of infection (MOI) of 0.1 and 
incubated (37 °C, 250 rpm, 1.5–2 hours) until a significant decrease 
in OD600 was observed. Chloroform (200 μL) was added directly to 
the lysate before centrifugation (12,000g, 5 min) to clear bacterial 
debris. The supernatant was sterile filtered (0.22 μm) and phage 
titers were determined by standard double overlay plaque assays. 
Phage samples with titer's exceeding 109 PFU mL−1 were further 
concentrated with the addition of PEG6000 (0.4%) & NaCl (0.3 M) 
and incubated (4 °C, 12–16 hours) to precipitate phage particles. 
The precipitated phage samples were centrifuged (35,000Xg, 2 
hours, 4 °C), the supernatant was discarded, the concentrated 
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phage pellet was re-suspended in Tris-HCl pH 7.4 (∼5 mL), sterile 
filtered (0.22 μm) and stored at 4 °C until needed. 
Bacteriophage genome preparation 
Aliquots (5 mL) of concentrated phage samples (>1011 PFU mL−1) 
were mixed with 4% SDS (5 mL) and incubated at 70°C for 20 
minutes. After cooling on ice, sodium acetate (2.55 M, 5 mL) was 
added before centrifugation (10,000 x g, 10 min). The supernatant 
was passed onto the Qiagen 100/G Genomic DNA column (Qiagen, 
Hilden, Germany) and phage genomic DNA was purified according 
to the manufacturer's instructions. DNA concentration was 
determined on a NanoDrop One (Thermo Scientific, Wilmington, DE, 
USA). 
Genetic engineering of bacteriophage T7 
A reporter enzyme expression construct was inserted into the phage 
T7 genome to create the reporter phage T7NLC (Fig. 1). In an effort 
to increase expression levels of NLuc, the strongest wild type T7 
promoter sequence51 was used to maximize transcription and a 
custom ribosome binding site (RBS) was designed to optimize 
translation.52 An N-terminal leader sequence (pelB) was added 
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immediately upstream of nluc as it has been shown to significantly 
increase soluble heterologous enzyme expression in E. coli53,54 by 
directing newly made proteins to the periplasmic space. Cleavage 
by a signal peptidase in the periplasm eliminates the 22 amino acid 
pelB sequence from the mature NLuc enzyme and confers no loss 
in enzymatic activity.55 The nluc and nluc::cbm genes were codon 
optimized with respect to the E. coli species within the T7 host range.   
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Figure 1: Schematic representation of phage genetic engineering. 
(A) The ∼1 kb NanoLuc expression construct was successfully 
integrated into the T7 phage genome (B) at a highly expressed 
region immediately downstream of the capsid gene. (C) Expression 
construct details: A T7 promoter (black arrow), a ribosome binding 
site (RBS; half circle), and a pelB leader sequence. The 
carbohydrate binding module (cbm2a) was fused to the C-terminus 
of nluc with a short flexible linker. (D) Schematic of the novel reporter 
fusion displaying binding affinity to cellulose. Genes/proteins/phages 
not drawn to scale for purposes of illustration.  
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The nluc & nluc::cbm expression constructs, used to make T7NL 
(accession number MH651797) and T7NLC (accession number 
MH651798) respectively, were expected to add 642 bp and 984 bp 
to the phage genome, respectively. Based on previous work with T7 
reporter phages bearing much larger reporters,31,56 the 1.7% (T7NL) 
and 2.6% (T7NLC) increases in genome size were expected to bear 
no significant reduction in fitness. 
A standard restriction digest was performed on the purified phage 
genome using HindIII-HF to create double strand DNA breaks at the 
insertion site. The NanoLuc reporter enzyme expression cassette 
was synthesized as a linear double stranded DNA molecule with 50 
bp of phage homology at each terminus. The insert was added to 
the digested phage genome at a 2:1 molar ratio and assembled with 
NEBuilder® Hifi DNA Assembly Master Mix (NEB, Ipswitch, MA), in 
accordance with the manufacturer's specifications. Insert 
confirmation was performed by PCR and DNA was purified using 
standard methods and resuspended in nuclease free water prior to 
transformation. The recombinant phage DNA was electroporated 
into E. coli DH10B cells (MegaX, New England Biolabs, Ipswitch, 
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USA). Sterile SOB media was added, and the transformed cells were 
incubated (37 °C, 2 hours) until visible lysis occurred. Chloroform 
(1–2 drops) was added to lyse any remaining cells and the mixture 
was centrifuged at 10,000 x g for 1 minute to clear bacterial debris. 
Following sterile filtration (0.22 μm), the transformation lysate was 
plated on a lawn of E. coli BL21 where individual plaques were 
isolated, resuspended in broth and insert confirmation done by PCR. 
Positive plaques were isolated, propagated and submitted for full 
genome sequencing. 
Bacteriophage T7NL & T7NLC stock preparation 
Due to their high sensitivity, it was necessary to remove excess 
reporter enzyme from the phage stock solutions so as to minimize 
background signal that could significantly impair the assay 
sensitivity. The concentrated phage sample (∼1011 PFU mL−1) was 
first diluted in sterile LB to a concentration of 109 PFU mL−1. For 
phage T7NLC, powdered microcrystalline cellulose (0.5 g) was added 
and the sample was placed on a rotational shaker for 30 minutes 
before sterile filtration (0.22 μm). The resulting phage stock was 
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tested for enzymatic activity and the cellulose sequestration 
procedure was repeated if detectable signal was generated. 
Reporter enzyme binding to cellulose 
The lysates resulting from infections between the engineered 
phages and E. coli were prepared as described above. In order to 
test the ability of the CBM to allow binding of the reporter enzyme to 
cellulose, the lysates were spotted onto regenerated cellulose filters, 
washed to remove unbound reporters, and then imaged following 
the addition of the NanoGlo substrate. 
Detection of log phase E. coli in broth 
Log phase E. coli 13706 cultures were obtained by adding overnight 
culture (200 μL) to fresh broth (5 mL). The culture was incubated (37 
°C, 250 rpm, ∼1 h) until an OD600 value of 0.8 was reached. Phage 
were added to serial dilutions of bacteria and incubated (37 °C, 250 
rpm, 90 min) for infection to occur. 
Following phage infection, an aliquot of each sample was added to 
a 384 well cellulose filter plate (AcroPrep 384 BioTrace NT, Pall, Port 
Washington, USA). Vacuum was applied according to the 
manufacturer's specifications until no liquid remained. NanoGlo 
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substrate was applied to each well (20 μL) and luminescence was 
measured on a plate reader (BioTek Synergy H1) with a 0.1 s 
integration time. While the vacuum filter plate provides a highly 
efficient capture mechanism for small sample volumes (∼200 μL), 
higher sample throughput becomes prohibitory when the large 
sample (100 mL) volumes required for regulatory testing are 
considered. 
Detection of stationary phase E. coli in lake water 
Lake water was collected from Lake Sammamish (WA) and used as 
a representative environmental sample matrix. Samples were 
filtered sterilized (0.22 μm), inoculated with E. coli 13707 (ATCC) 
and left at room temperature for 2 days. After 48 hours, samples 
were diluted in LB and incubated (37 °C, 250 rpm) for various time 
intervals. Following enrichment, T7NLC phage (107 PFU mL−1) was 
added and luminescence was measured using 384 well filter plates 
as described previously. 
Drinking water assay 
A phage-based drinking water assay was developed as a proof of 
principle to detect E. coli in 100 mL of drinking water using the 
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recombinant T7NLC reporter phage (Fig. 2). Drinking water samples 
(100 mL) were autoclaved and inoculated with various 
concentrations of stationary phase E. coli BL21. Sterile concentrated 
5× LB media (25 mL) was added to the sample and incubated (37 
°C, 225 rpm, 60 min) to allow resuscitation of injured or stressed E. 
coli cells. Following pre-enrichment, phage stock (1 mL of 109 PFU 
mL−1) and microcrystalline cellulose (0.05 g) were added and 
incubated (37 °C, 225 rpm, 90 min) to allow for phage infection and 
reporter enzyme production. NanoLuc-CBM complexed with the 
microcrystalline cellulose was pelleted by low speed centrifugation 
(3000g, 5 min). The bulk lysate was decanted, and the cellulose 
pellet was resuspended directly in NanoGlo substrate and 
immediately evaluated for luminescence.  
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Figure 2: Schematic representation of detection assay. The water 
sample is first supplemented with concentrated growth media (5× 
LB) to allow resuscitation of E. coli. After an incubation period, the 
phage and cellulose are added to the sample and the infection 
incubation period begins, during which expression of NanoLuc-CBM 
occurs. The reporter enzyme then binds to the cellulose which is 
collected for analysis.
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Bulk lysate luminescence was evaluated for both T7NL and T7NLC 
phages by adding equal volumes of the corresponding lysate (100 
μL) to undiluted NanoGlo substrate (100 μL), in accordance with the 
manufacturer's specifications. Controls included uninfected bacterial 
cultures with no phage and phage alone. Measurements were 
performed in opaque white 96 well plates on a luminescent plate 
reader (Biotek, Winooski, VT, USA). Luminescent intensity was 
reported as relative luminescence units (RLU) using an integration 
time of 0.1 s. Samples were evaluated in triplicate and reported as 
the mean ± standard deviation. The limit of detection was 
determined using the sum of the negative control and three standard 
deviations (0 + 3SD) as the lowest detectable signal.57–60 
RESULTS & DISCUSSION 
Reporter phage construction & isolation 
The nluc & nluc::cbm reporter genes were synthesized within 
expression constructs and successfully inserted into phage T7 to 
generate reporter phages T7NL & T7NLC, respectively. Plaques were 
screened initially by the direct addition of substrate followed by PCR. 
Plaque morphologies for both recombinant phages similar identical 
to wild type phages. The burst size and lysis times were also 
comparable to the wild type, suggesting no measurable loss of 
fitness (data not shown). Correct insertion of the nluc & nluc::cbm 
expression constructs were confirmed via PCR using external 
screening primers. Sanger sequencing results revealed the correct 
642 bp & 984 bp insertions, for T7NL and T7NLC respectively, without 
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other significant mutations, insertions or deletions within the 
insertion site. 
Characterization of phage infection 
Infection of E.coli BL21 with recombinant reporter phage transduced 
the nluc::cbm gene into the target bacterial cell where the reporter 
enzyme was successfully expressed. As seen in Fig. 3, a 
characteristic phage infection was performed to evaluate the 
phage's ability to lyse target cell populations and express reporter 
enzyme by measuring luminescence intensity and optical density at 
regular intervals. Post phage addition, a plateau in the OD600 
occurred after approximately 30 minutes.  
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Figure 3: Optical density and luminescence of E. coli samples before 
and after the addition of the phages. The optical density briefly 
increased following the addition of reporter phage (indicating steady 
state growth) then rapidly dropped as cells lysed. Data points 
represent the average of three replicates and error bars represent 
the standard deviations. 
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The bioluminescent signal generation was relatively fast following 
phage addition. While some of the rapid signal generation is due to 
the carryover of reporter enzyme from the phage lysate, the plateau 
of the signal occurs 40–50 minutes after phage addition. The final 
phage stock concentration (107 PFU mL−1) was used to maintain an 
MOI > 1 and therefore minimize the time required for the assay. Lysis 
times are shortest when phages outnumber bacteria because phage 
adsorption times are near instantaneous and co-infections could 
possibly deliver multiple copies of reporter enzyme DNA.61,62  
Reporter enzyme binding to cellulose 
In order to confirm the ability of the CBM to immobilize the enzyme 
onto cellulose, lysate resulting from the respective infections of T7NL 
and T7NLC with E. coli BL21 were spotted onto regenerated cellulose 
filter papers. NanoGlo was then directly added to some of the filters 
and imaged, while another set of filters was washed prior to the 
addition of substrate. The results demonstrated a spreading of the 
bioluminescence in relation to the original deposition spot for the 
T7NL on unwashed filters, while the T7NLC luminescence remained 
limited to the original lysate spot. Additionally, the washed filters had 
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a significant drop in bioluminescence for the T7NL, while the T7NLC 
was similar to the unwashed filters (data not shown). This suggested 
that the CBM facilitated to the immobilization of the reporter enzyme 
onto cellulose. 
Performance of T7NLC for E. coli detection 
The ability of T7NLC to overexpress reporter enzymes in target 
bacterial hosts in different stages of growth was evaluated. 
Exponentially growing cells in broth were infected to evaluate the 
minimum number of cells required to produce a detectable signal 
and thus establish a limit of detection. The resulting lysate was 
vacuum filtered through a cellulose membrane on a filter plate to 
immobilize the reporter enzyme. Fig. 4 indicates that when coupled 
with a highly efficient capture mechanism, a detectable signal can 
be generated from an infection between T7NLC and <10 mid-log 
phase bacteria. 
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Figure 4: The number of E. coli CFUs needed to produce a detectable signal was 
determined by phage infecting serial dilutions of E. coli and passing them through a 
filter plate. The “phage only” negative control (solid horizontal line) is represented 
±standard deviations (dashed lines). Data points represent the average of six replicates 
and error bars represent standard deviation. 
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 Furthermore, an apparent linear relationship between the E. coli 
population and the resulting bioluminescent signal was observed, 
indicating that the T7NLC phage can be used to approximate bacterial 
concentrations from a single CFU to over 103 CFU mL−1.  
To approximate realistic analytical conditions, E. coli were left in 
sterile filtered lake water for 48 hours to ensure they reached 
stationary growth phase. Cells were then enriched and infected with 
T7NLC to evaluate the phage's effectiveness in representative 
drinking water samples. As seen in Fig. 5, E. coli rapidly reached 
steady state growth allowing a starting concentration of <10 CFU E. 
coli to become detectable after only 3 hours of enrichment. 
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Figure 5: Stationary phase E. coli inoculated into lake water was 
enriched from 1 to 5 hours prior to being infected with T7NLC. The 
results indicate that after 3 hours of enrichment, <10 CFU of E. coli 
are detectable from lake water. The “phage only” negative control 
(solid horizontal line) is represented as ±standard deviations 
(dashed lines). Data points represent the average of three replicates 
and error bars represent the standard deviation. 
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Phage-based assay conditions for the detection of E. coli in 100 mL 
water samples 
The T7NLC phage was used to detect E. coli from 100 mL samples of 
water. Water samples were inoculated with varying concentrations 
of E. coli in order to determine the limit of detection for the assay. 
Prior to phage/cellulose addition, a 60 minute pre-enrichment step 
served to resuscitate any bacterial cells that were injured or had 
reached stationary growth (Fig. 2). While the time can be varied 
according to host growth rates, the pre-enrichment step is critical for 
a phage-based assay because phage require an actively growing 
host for successful infection.63 Although two recombinant phages 
were generated in this work, only T7NLC, which employed the 
cellulose affinity tag, was selected for the final detection assay. As 
seen in Fig. 6, the detectable NanoLuc signal was closely correlated 
with the bacterial cell population. The detection limit for T7NLC is <10 
CFU mL−1 in a total assay time of 3 hours.  
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Figure 6: Drinking water (100 mL) containing E. coli BL21 was used 
to determine the dose response of the phage-based assay. Within 
the range tested, increasing E. coli concentrations correlated with 
stronger bioluminescent signal. The limit of detection was defined as 
the negative control (0 CFU mL−1) plus three standard deviations. 
Data points represent the average of three replicates and error bars 
represent the standard deviation. 
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Furthermore, the results seen in Fig. 4 suggest a lower limit of 
detection is achievable and therefore it is likely that the 
demonstrated 100 mL water assay is: (i) not efficiently infecting the 
E. coli in the larger samples, or (ii) the free cellulose is not efficiently 
capturing the fusion reporter released from the resulting infections. 
Additionally, the effect of nonspecific binding must be taken into 
account as well. It is possible that some signal is lost due to the 
binding of the reporter enzyme to carbohydrates within the bacterial 
cell as well as nonspecific interactions with the polypropylene tubes 
used for the assay.48  
CONCLUSION 
Current methods for the detection of microorganisms in food 
samples are largely culture based, requiring trained laboratory 
personal multiple days before a definite result. Furthermore, many 
pathogenic strains of E. coli have such low infectious doses (<100 
CFU) that the development of rapid and sensitive detection schemes 
is required to adequately mitigate potential risk to public health. The 
successful integration of a newly developed, highly active luciferase 
gene (nluc) into a phage genome, created a reporter phage capable 
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of rapidly detecting low concentrations of E. coli. The nluc gene was 
synthesized within an expression construct specifically engineered 
for T7 expression. Overexpression of the nluc gene was achieved 
by optimization of regulatory sequences as well as by insertion of 
the reporter into a highly expressed region of the phage genome. 
The expression construct employed the strongest native T7 
promoter sequence, a custom ribosome binding site, a pelB leader 
sequence, and a codon optimized nluc gene. Finally, the most 
significant development of this work was the genetic fusion of a 
carbohydrate binding module (cbm2a) to NanoLuc within the 
previously described expression construct. As a result, the 
functionalized reporter was successfully concentrated through 
immobilization onto inexpensive, inert, insoluble microcrystalline 
cellulose. Microcrystalline cellulose dispersed into the bacteria-
phage complex successfully captured the novel chimeric 
NanoLuc::CBM produced as a result of target cell infection. 
Following a full phage infection, the cellulose can be either actively 
pelleted by centrifugation or passively separated by gravity 
depending on access to resources. The insoluble cellulose pellet 
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can be resuspended in enzyme substrate for immediate 
measurement or in a biological buffer for downstream applications. 
The use of cellulose to collect the reporter probe from the bulk 
sample solution served to reduce the overall sample volume by over 
2 orders of magnitude. This was achieved by separating the 0.05 g 
cellulose added to the 125 mL sample and resuspending the 
cellulose-enzyme complex in less than 1 mL of substrate following 
phage infection. Future studies using cellulose filters to capture the 
reporter probes may demonstrate a significant improvement in the 
capture of the NanoLuc::CBM resulting in a lower limit of detection. 
The light emitted from NanoLuc is bright blue as evidenced by a 
sharp emission peak at 450 nm. When images of NanoLuc are 
separated in RGB channels, over 98% of signal emitted resides 
within the blue channel.64 As a result, NanoLuc has significant 
potential to be incorporated into a multiplex recombinant phage 
biosensor (i.e. NanoLuc + Red and/or Green luciferases inserted 
into phages with different host ranges) that would be capable of rapid 
and simultaneous differentiation of specific analytical epitopes.  
Areas for further optimization include broadening phage host range, 
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increasing enzyme expression during phage infection, and 
minimizing the enzymatic loss of activity when genetically fusing 
affinity binding ligands. Genetic modifications to the tail fibers of T7 
have been shown to successfully expand the range of permissive 
hosts.24 Similar genetic engineering would be straightforward with 
T7NLC as the NanoLuc expression cassette bears no effect on the tail 
fibers. Increased enzyme expression will be achieved by further 
optimization of regulatory and signal sequences as well as the insert 
location within the phage genome. The optimal leader sequence 
must be proven empirically, as leader sequences other than pelB 
have been shown to significantly increase expression as well.55 
Furthermore, optimization of the linker sequence between NanoLuc 
and the CBM could function to fully retain enzymatic activity of our 
novel chimeric reporter as compared to the standard NanoLuc 
enzyme. Expression of a reporter enzyme with a CBM causes 
binding to cellulosic entities within the cell during expression as well 
as plastic species within standard laboratory tubing and glassware. 
Blocking of plastics with 1% BSA should lead to additional 
efficiencies and a lower limit of detection.48  A current limitation to 
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phage-based assays remains the need for cocktails of phages in 
order to cover the desired host range. This is due to the high 
specificity of the phages which can often be limited to single strains. 
Ongoing work by the authors and other labs aims to customize the 
tail fibers of phages to allow tailored host ranges. Such work will 
allow a better utilization of phages as both detection and therapy 
tools. 
CONCLUSION 
Our results suggest that our novel recombinant phages are ideal for 
an ultrasensitive bacterial detection assay. Our proof-of-principle 
detection assay utilizes recombinant phages that express novel 
chimeric reporter enzymes to rapidly and sensitively detect less than 
10 CFU mL−1E. coli. Lower limits of detection can be reached by 
increasing the pre-enrichment times thereby allowing the bacteria to 
reach a higher concentration.  As we demonstrated the successful 
genetic engineering of a phage to sensitively detect E. coli, similar 
efforts could provide low cost detection assays to other fields 
burdened with bacterial threats including food and water safety, 
medical diagnostics, animal health, and bio threat detection. 
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A PHAGE-BASED ASSAY FOR THE RAPID, QUANTITATIVE, AND 
SINGLE CFU VISUALIZATION OF E.COLI (ECOR #13) IN 
DRINKING WATER* 
 
 
 
 
 
 
 
 
 
 
 
*Troy C. Hinkley, Sangita Singh, Spencer Garing, Anne-Laure M. Le 
Ny, Kevin P. Nichols, Joseph E. Peters, Joey N. Talbert & Sam R. 
Nugen 
 108 
ABSTRACT 
Drinking water standards in the United States mandate a zero 
tolerance of generic E. coli in 100 mL of water. The presence of E. 
coli in drinking water indicates that favorable environmental 
conditions exist that could have resulted in pathogen contamination. 
Therefore, the rapid and specific enumeration of E. coli in 
contaminated drinking water is critical to mitigate significant risks to 
public health. To meet this challenge, we developed a 
bacteriophage-based membrane filtration assay that employs novel 
fusion reporter enzymes to fully quantify E. coli in less than half the 
time required for traditional enrichment assays. A luciferase and an 
alkaline phosphatase, both specifically engineered for increased 
enzymatic activity, were selected as reporter probes due to their 
strong signal, small size, and low background. The genes for the 
reporter enzymes were fused to genes for carbohydrate binding 
modules specific to cellulose. These constructs were then inserted 
into the E. coli-specific phage T7 which were used to infect E. coli 
trapped on a cellulose filter. During the infection, the reporters were 
expressed and released from the bacterial cells following the lytic 
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infection cycle. The binding modules facilitated the immobilization of 
the reporter probes on the cellulose filter in proximity to the lysed 
cells. Following substrate addition, the location and quantification of 
E. coli cells could then be determined visually or using 
bioluminescence imaging for the alkaline phosphatase and 
luciferase reporters, respectively. As a result, a detection assay 
capable of quantitatively detecting E. coli in drinking water with 
similar results to established methods, but less than half the assay 
time was developed. 
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INTRODUCTION 
Clean drinking water has been declared a fundamental human right, 
yet millions still lack access to consistently clean sources of potable 
water1. Pathogenic Escherichia coli (E. coli), a common drinking 
water contaminant, is a major cause of morbidity and mortality 
worldwide. While the WHO estimates approximately 63,000 annual 
deaths are due to E. coli infections, the added consequence of 5 
million years of life lost (YLLS) and 5 million disability adjusted life 
years (DALYS) further compounds the suffering caused by this 
pathogenic contaminant2. In addition to GI tract infections, E. coli is 
responsible for 8.9% of sepsis cases, 29% of early onset neonatal 
sepsis cases and the majority of urinary tract infections3,4. Generic 
E. coli species which consist of both pathogens and non-pathogens, 
are ubiquitous in mammalian feces5,6,7,8,9. Because these organisms 
are naturally found in the feces of mammals in high concentrations, 
their presence is a biological indicator of fecal contamination and 
therefore possible pathogens in drinking water10. 
The United States EPA and FDA have set a limit of zero CFU generic 
E. coli in 100 mL for drinking water and postharvest produce rinse 
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water, respectively. Untreated agricultural water, such as that used 
for irrigation, has a maximum geometric mean (GM) of 126 CFU or 
less with a statistical threshold value (STV) of 410 or less of generic 
E. coli in a 100 mL sample11. These same requirements are used by 
the EPA for untreated recreational water. EPA Method 1603 is an 
approved drinking water assay that quantifies generic E. coli with an 
assay time of 24 hours. This drinking water assay contains a 
membrane (0.45 µm) filtration step to remove bacteria from the water 
sample prior to enrichment on selective and differential media. The 
bacteria CFUs are quantified directly on the filter following a lengthy 
enrichment12. 
An alternative assay used to detect generic E. coli in agricultural and 
produce rinse water is the most probable number (MPN) method. 
The MPN is determined by serial diluting the water sample in 
triplicate or pentaplicate followed by incubation in selective growth 
media. The tubes are then assessed for bacterial growth and the 
highest dilution numbers for each replicate are used to statistically 
estimate the MPN of the original sample. 
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While both EPA 1604 and MPN can detect a single E. coli CFU in 
100 mL of water, the prolonged incubation periods necessary for 
visual identification make them less practical for time sensitive 
applications. For example, the days required to receive results for 
drinking water or recreational water may be too long to prevent 
individuals from becoming infected. Similarly, the results for E. coli 
counts in produce rinse water may not be available until after the 
produce has been sold and consumed. Due to rapid spoilage, many 
types of produce may be sold and consumed before microbial results 
from traditional methods are available. Therefore, there is a 
significant need to rapidly detect E. coli in water samples while 
maintaining high sensitivity and quantification. 
While the identification of indicators and/or pathogens often involves 
culturing of serological, food, or environmental samples, new 
technologies aim to significantly decrease assay times. Although 
some advanced technologies (e.g. optical nanostructures, surface 
enhanced Raman spectroscopy, flow cytometry, etc.) have shown 
promise as sensitive detection methods, they typically process only 
small, relatively clean samples. The true bottleneck to rapid 
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detection methods remains the separation of a target analyte from a 
large complex matrix. 
Currently, a pragmatic system that integrates sample preparation 
and rapid pathogen detection from large volume samples remains 
elusive. While the vast majority of research focuses on improving 
sensitivity of pathogen detection rather than 
separation/concentration, an ideal detection platform would 
incorporate all these components into one rapid, sensitive and 
specific detection assay. Additionally, while some regulations may 
be satisfied with binary presence/absence results, others, such as 
those for irrigation water and untreated recreational water require 
quantitative results. Therefore, there is a need to develop a rapid 
detection assay with the ability to detect 1 CFU/100 mL of viable 
target bacteria, while also providing fully quantitative results. These 
attributes mimic those of the current EPA 1603 method which is 
widely used for the testing of generic E. coli from water samples. 
A new generation of rapid tests to detect bacteria utilize engineered 
bacteriophages13,14. Bacteriophage (phages) are viruses that infect 
bacteria in a strain-specific manner. Phages exhibit specific host 
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ranges due to the complex interactions involved in phage 
attachment to the bacterial cell surface. Following adsorption, the 
phage injects its genome into the bacterial host and initiates 
infection. Then bacterial DNA transcription and translation systems 
begin the process of replicating many more infectious phage 
particles along with the lytic enzymes responsible for eventual 
bacterial lysis. These viral predators contain robust biorecognition 
elements commonly employed in sensitive bacterial detection 
assays13,14,15,16,17,18,19,20,21,22. We took advantage of a naturally 
evolved viral infection process that dramatically alters bacterial 
protein expression to overexpress engineered reporter enzymes. 
While, previous studies have reported the integration of phage-
based testing and filtration for water testing, the migration of reporter 
probes prohibited full quantification and single CFU visualization23. 
We hypothesized that the fusion of an affinity binding module to the 
reporter probe could effectively immobilize the probe in vicinity to the 
lysed bacterial host, allowing improved quantification. Therefore, a 
phage-based detection assay for generic E. coli, modeled after the 
widely used membrane filtration assay, EPA Method 1603, for 
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drinking water was developed. First, highly active reporter enzymes 
was genetically fused to a carbohydrate binding module (CBM) with 
specificity for cellulose. The reporter enzymes were then genetically 
engineered into a phage specific to E. coli. Following infection, the 
bacteria trapped on a cellulose filter lysed releasing the reporter 
probes, which then immobilized locally. The addition of 
bioluminescent or colorimetric substrates allowed a visual 
quantification of the host E. coli colonies on the filter. Here we 
integrate several technologies to construct a phage-based detection 
platform that is quantitative and can allow the visualization of 
individual CFU’s from a 100 mL water sample. The power of our 
approach is that it integrates a custom phage that produces a highly 
active fusion enzyme which can be immobilized to allow improved 
quantification. 
MATERIALS & METHODS 
Reagents and materials 
The luminescent substrate, NanoGlo, was purchased from Promega 
(Madison, WI, USA) and prepared immediately before use according 
to the manufacturer’s specifications. All other reagents were 
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purchased from Sigma Aldrich (St. Louis, MO, USA) unless stated 
otherwise. The colorimetric phosphatase substrate, 5-bromo-chloro-
3-indolyl-phosphate p-toluidine salt (BCIP), was prepared as a stock 
solution (20 mg/mL) in N,N-Dimethylformamide (DMF) and stored at 
−20 °C. A BCIP working solution (2 mg/mL) was prepared in 1 M 
Diethanolamine (DEA) buffer immediately prior to use. 
Bioluminescent images were captured using long exposures (30 s) 
with a DSLR camera (Rebel T6, Canon, Melville NY, USA) in a dark 
box (LTE-13, Newport Corporation, Irvine, CA, USA). Nalgene™ 
disposable analytical test filter funnels (145-0045) for water testing 
were used to house the regenerated cellulose filters (Sartorius 
Stedim Biotech GmbH, Goettingen, Germany). All filters were 47 mm 
diameter with a 0.22 µm pore size. 
Bacteria, phages and culture media 
E. coli BL21 was obtained from ATCC (Manassas, VA USA) and E. 
coli (ECOR #13), a strain isolated from a healthy human, was 
obtained from the Thomas S. Whittam STEC Center (East Lansing, 
MI, USA). Bacterial cultures were initially stored at −80 °C in 25% 
glycerol prior to use and were grown in Luria Bertani (LB) broth and 
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plated on LB agar. Overnight cultures of E. coli were prepared in 
10 mL of LB inoculated with a single bacterial colony and incubated 
(37 °C, 200 rpm, 18 hr). Serial dilutions were performed in sterile 
phosphate buffer saline (PBS). Bacteria and phages were 
enumerated using standard plate counts and double overlay plaque 
assays, respectively. The lytic coliphage T7 (T7Select 415-1) used 
in this work was designed as a cloning vector for routine phage 
display applications. The phage DNA used in this study was purified 
from propagations of T7Select 415-1 DNA in E. coli BL21, purchased 
from EMDMillipore (Burlington, MA, USA). 
Phage Stock Solutions 
Exponentially growing host cells (200 mL) were infected with phage 
at an MOI of 0.1 until cellular lysis caused a significant decrease in 
OD600 (1.5–2 h). Low speed centrifugation was used to clear 
cellular debris (3,200 × g, 10 min, 4 °C) before sterile filtration 
(0.22 µm). Polyethylene glycol 6000 (PEG6000; 4%) and sodium 
chloride (NaCl; 0.4 M) were added and incubated overnight at 4 °C 
to precipitate phage particles. Phage were pelleted by 
ultracentrifugation (35,000 × g, 120 min, 4 °C), resuspended in 
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phosphate buffered saline (PBS, pH 7.4), enumerated, and stored 
at 4 °C. All phage used in detection assays were diluted to 1 × 109 
PFU/mL in LB, sterile filtered (0.22 µm) and stored at 4 °C. 
Phage DNA Isolation 
Phage lysates of sufficient concentration (>1011 PFU/mL) were used 
for genome extraction and purification. The phage stock solution 
was treated with sodium dodecyl sulfate (SDS; 2%) for 20 min. at 
70 °C to disrupt the capsid release phage genomic DNA. After 
cooling on ice, DNA was precipitated with sodium acetate (0.3 M) 
and ethanol (70%). The sample was centrifuged (10,000 × g, 10 min, 
4 °C) and the supernatant was passed through the Qiagen Genomic 
Tip 100/G according to the manufacturer’s recommendations. 
Reporter Enzyme Expression Constructs 
A phosphatase and luciferase were chosen as reporter enzymes to 
transduce colorimetric and luminescent signals, respectively. Muller 
et al. performed random mutagenesis on bacterial alkaline 
phosphatase and demonstrated that two amino acid substitutions 
(D153G/D330N) increased enzymatic activity by more than two 
orders of magnitude26. Similarly, Hall et al. engineered a 
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bioluminescent enzyme and substrate system (NanoLuc & NanoGlo, 
respectively) capable of generating a much stronger signal 
compared to other commonly employed luciferases24. An affinity 
binding motif with irreversible binding to crystalline cellulose 
(CBM2a) was identified in the xylanase 10 A gene from 
Cellulomonas fimi33, and employed as a genetic fusion to specifically 
immobilize the chosen reporter enzymes34. The CBM gene was 
genetically fused to the C-terminus of the reporter enzyme while a 
strong T7 promoter and ribosome binding site were inserted 
upstream to force high levels of expression. Finally, the expression 
cassette was flanked by regions homologous to the phage 
multicloning site and synthesized as a double stranded DNA 
fragment by IDT (Coralville, Iowa, USA). 
Construction & Isolation of Reporter Phages 
Phage genomic DNA was isolated and purified from propagations of 
T7 Select 415-1 as described previously. Purified phage DNA was 
digested with HindIII to prepare the vector for reporter gene 
insertion. The reporter gene, containing homology to each vector 
arm, was added to the phage genomic vector at a 2:1 molar ratio 
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and was assembled using NEBuilder® Hifi DNA Assembly Master 
Mix (NEB, Ipswitch, MA). Transformations were performed in 
electrocompetent E. coli DH10B (MegaX, ThermoFisher) in 1-mm 
cuvettes under standard conditions. Recovery was performed in 
SOB with shaking until visible signs of lysis occurred. Serial dilutions 
were performed until double overlay plaque assays revealed 
individual plaques. Correct clones were identified with application of 
enzymatic substrate and imaging as described previously. Positive 
plaques were further evaluated using PCR to verify insert size and 
full genome sequencing. The constructs for the inserted genes are 
shown in Fig. 1. 
Enzyme Substrates & Imaging 
Alkaline Phosphatase 
The phosphatase substrate 5-bromo-4-chloro-3-indolyl-
phosphatase, 4-toluidine salt (BCIP) was dissolved in DMF 
(20 mg/mL) and stored at −20 °C. Immediately before use, BCIP 
stock was diluted tenfold in diethanolamine buffer (1 M DEA, pH 
10.1) and applied directly to the filter. A short incubation (37 °C, 
10 min.) generated sufficient color development for imaging. All 
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images were captured with a DSLR camera on an LED light box 
(AGPTek, Brooklyn, NY, USA). 
 122 
 
Figure 1: Reporter enzyme fusion design for the engineered 
bacteriophages. Reporter genes were synthesized within expression 
constructs as described previously.  The inserted nucleic acid 
lengths for a) alkaline phosphatase, b) alkaline phosphatase + CBM, 
c) NanoLuc and d) NanoLuc + CBM are shown in relative scale. The 
resulting proteins (e) are represented in scale using pdb files 5ibo, 
1kh7, 1exg for NanoLuc, Alkaline Phosphatase and CBM2a, 
respectively. 
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NanoLuc 
NanoGlo buffer was prepared according to the manufacturer’s 
recommendations immediately before use. The filter membranes 
were fully saturated in substrate (~300 µL) prior to imaging. Long 
exposure bioluminescent images were captured with a DSLR 
camera in a dark box using 30 second exposure times. 
Assay procedure 
The phage-based procedure used the initial filtration steps of EPA 
method 1603 followed by phage infection and imaging (Fig. 5). 
Drinking water samples (100 mL) were obtained from a local 
municipal water source (Ithaca, New York, USA) and autoclaved. 
The sterile drinking water samples were inoculated with varying 
concentrations of stationary phase E. coli (ECOR #13) and filtered 
according to the procedure outlined in EPA Method 1603. Following 
filtration, the filter membrane was removed and placed onto an 
absorbent pad saturated with LB broth. The filters were incubated 
(37 °C, 8–12 hours) to allow for colony growth. Following the initial 
enrichment, a phage solution (2 mL, 109 PFU/mL in LB) was applied 
to the filter and incubated (37 °C, 90 min) to initiate phage infection 
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and reporter probe expression. After brief drying on a sterile 
absorbent pad, the enzymatic substrates were applied and imaged 
as described previously. 
In order to characterize the performance of the phage-based 
method, the concentration of E. coli in the water samples was 
determined in parallel using the EPA method 160312. 
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Figure 5: Schematic diagram of the phage-based detection assay. a) The 100 mL water 
sample passes through the filter, retaining any bacterial contaminants. b) The filter is 
placed on media and incubated to allow for colony formation. c)  Recombinant phages 
are added to force expression of the desired reporter.  d) Substrate addition provides a 
colorimetric signal for NRGp2 and a bioluminescent signal for NRGp4. 
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 Following filtration, the filter was placed onto modified mTEC agar 
and incubated according to the methods specifications. Colonies 
were counted after the required 24-hour incubation period. 
Image analysis 
Images of the bioluminesnce on the capture filters were analyzed 
using ImageJ. The relatively low background of the bioluminescent 
images allowed the pixel intensities to be multiplied by three 
resulting in an improved visualization of the spots. The spots were 
counted both visually as well as using the imageJ software to allow 
a determination of the accuracy of the image analysis. Spot sizes 
and distribution were determined using ImageJ particle size 
distribution. 
RESULTS 
Phage Construction, Isolation & Characterization 
The alp, alp::cbm and luc, nluc::cbm reporter genes were 
successfully inserted into coliphage T7 to generate the reporter 
phages NRGp1 (MH651795), NRGp2 (MH651796), NRGp3 
(MH651797), & NRGp4 (MH651798), respectively. Initial screening 
was performed using PCR and Sanger sequencing was used for 
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validation. Full genome sequencing revealed no significant 
mutations in the remainder of the genome. No significant differences 
in plaque morphology, burst size and/or lysis times were observed 
between the recombinant and wild type phages (data not shown). 
Reporter probe characterization 
NanoLuc, a luciferase engineered from deep sea shrimp, was 
selected as a luminescent reporter due to its strong signal, small size 
and low background24. NanoLuc is an ideal reporter enzyme 
candidate for this work as it has previously been employed in phage-
based detection assays13 and also as a genetic fusion partner25. The 
alkaline phosphatase double mutant was selected as a colorimetric 
reporter due to its high enzymatic activity, low background and the 
wide variety of substrates available26. 
We used the lytic phage T7, originally designed as a phage display 
platform (T7 Select), which contains a multiple cloning site directly 
downstream of the capsid gene27,28. The expression cassette 
contained a stop codon upstream of the reporter in order to highly 
express the standalone reporter enzyme as opposed to the capsid 
fusion commonly employed in phage display. This insertion location 
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has previously been used in both phage display29 and reporter 
phage applications15,30. Furthermore, the strong phi10 T7 promoter31 
and a custom ribosome binding site were used to promote enzyme 
expression32. 
The enzymatic activity of the two reporters used, alkaline 
phosphatase and NanoLuc luciferase, have been engineered to be 
over two orders of magnitude greater than their respective 
counterparts24,26. In this work, these two highly active enzymes were 
functionalized with an affinity binding motif through the genetic 
fusion of a carbohydrate binding module (CBM) from Cellulomonas 
fimi with specificity to cellulose (CBM2a). As seen in Fig. 1, four total 
recombinant phages were generated (two of which carried celulose 
binding functionality) and were used in detection assays. 
To evaluate the binding affinity of the CBM fusions, phage lysates 
containing the respective reporter enzyme were slowly spotted onto 
the center of a cellulose filter allowing for passive diffusion to 
completely saturate the membrane. Following drying in ambient air, 
the respective substrates were applied and images of the filters were 
captured. As seen in Fig. 2, T7 with a NanoLuc + CBM gene 
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(NRGp4) and T7 with an alkaline phosphatase + CBM gene (NRGp2) 
displayed limited diffusion and a stronger, concentrated signal 
whereas T7 with a NanoLuc gene (NRGp3) and T7 with an alkaline 
phosphatase gene (NRGp1) both exhibit significant diffusion and 
signal dilution. Similar relative binding affinities were displayed when 
the filters were washed with a biological buffer prior to substrate 
addition. To a lesser extent, the same phenomenon was observed 
when the respective phages were used in the detection assay. 
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Figure 2: Reporter probes fused with a carbohydrate binding module significantly limits 
diffusion across. The reporter probes were spotted (1 mL) onto the center of the filter 
until the entire filter was saturated by diffusion.  The effect of the carbohydrate binding 
module (CBM) fusion to the reporter enzymes was visualized by the degree of diffusion 
from the center of the filter (top row).  The binding strength was further evaluated by 
washing the filter with PBS before substrate addition (bottom row). 
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Detection of E. coli colony forming units 
Determination of assay time 
Detection assays employing membrane filtration require pre-
enrichment to allow the bacteria on the filter to grow to a sufficient 
density cells at which a detectable signal can be generated. The 
amount of pre-enrichment needed for a bacterial colony to grow to a 
detectable size depends on several factors (generation time, growth 
conditions, reporter enzyme kinetics, etc.) and was investigated for 
the proposed assay. While the first visible indication of colony 
formation occurred well before 8 hours of pre-enrichment for ECOR 
#13, 8 hours was selected as the ideal pre-enrichment time to 
minimize false negative results by ensuring that smaller colonies 
grew large enough to produce a measurable signal. With only 90  
minutes required for phage infection and 15 minutes for substrate 
addition and imaging, our phage based detection assay provided 
quantifiable results in less than half the time of traditional detection 
assays. 
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Visualization of colonies 
The NanoLuc enzyme, when complexed with its substrate NanoGlo, 
exhibits a blue luminescent signal with a peak emission at 460 nm. 
To mitigate signal decay, a camera was placed in close proximety to 
the cellulose filters. Although alkaline phosphatase has a wide range 
of available substrates, the colorimetric substrate 5-bromo-chloro-3-
indolyl-phosphate p-toluidine salt (BCIP) was used to visualize 
bacterial colonies infected with either NRGp1 or NRGp2. The 
insoluble blue precipitate which formed as a reaction product 
between alkaline phosphatase and BCIP was easily visualized by 
the naked eye, with no requirements for specialized equipment (Fig. 
3). 
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Figure 3: Visual comparison of the EPA method 1603 with the phage-based methods. 
While the EPA method requires a significantly longer time for results, the use of phage-
based reporters allows a more rapid determination. The times listed are the total assay 
times including incubation. All filters diameters are 47 mm. 
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Phage Based Detection vs. EPA Method 1603 
EPA Method 1603 requires pre-enrichment on selective and 
differential media (modified mTEC) to enumerate total coliforms for 
water quality testing. Drinking water samples were spiked with 
varying concentrations of E. coli (ECOR #13) and evaluated using 
EPA Method 1603, the NRGp4 phage method, and the NRGp2 
phage method. 
The phage-based methods used 8 hours of pre-enrichment, followed 
by a 90-minute phage infection period. From initial filtration to final 
results, the total assay time for the phage-based methods was 
approximately 10 hours, whereas the EPA method requires 24 hours 
before accurate counts could be observed. Images of representative 
filters are shown in Fig. 3. 
Each dilution of E. coli was run in triplicate for each of the three 
methods. A negative control containing no inoculated E. coli was 
also for all methods. The CFU counts for the methods were 
compared to determine agreement. For each dilution, EPA Method 
1603 was compared to the NRGp4 method resulting in a linear 
relationship with a slope of 0.89 (R2 = 0.99). Similarly, EPA Method 
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1603 was compared to the NRGp2 method resulting in a linear 
relationship with a slope of 1.02 (R2 = 1.00). As seen in Fig. 4, the 
variations observed between the phage-based methods falls within 
the variation of the EPA test. Two-factor ANOVA with replication was 
used to determine the difference between EPA Method 1603 and the 
two phage-based methods at the several bacteria concentrations 
reported. The results indicate there was no significant difference at 
the p < 0.01 level, between EPA Method 1603 and the NRGp2 
method [F(1,3) = 1.105, p = 0.306] and EPA Method 1603 and the 
NRGp4 method [F(1,3) = 1.667, p = 0.689]. We can conclude that 
both the phage-based tests fall within the natural variation of the 
accepted EPA Method 1603 at low bacterial concentrations, and 
therefore provide comparable results in less than half the time. 
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Figure 4: Performance comparison of the phage-based methods against the approved 
EPA Method 1603. Dilutions of E. coli in 100 mL of water were tested in triplicate using 
all three methods. Both NRGp2 (ALP+CBM) and NRGp4 (NanoLuc+CBM) methods 
showed similar CFU counts over the different concentrations. Error bars represent the 
standard deviation of three replicates. 
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DISCUSSION & CONCLUSION 
Detection of bacterial pathogens or their indicators in larger samples 
of water is critical to ensuring safe drinking water in developing 
countries. Given the zero tolerance regulatory requirements for 
drinking water of 0 CFU/100 mL, sample sizes below 100 mL risk the 
possibility of false negative results. Additionally, concentration 
methods which result in low capture efficiencies could also 
contribute to false negatives. We have developed a phage-based 
detection assay that utilizes the cellulosic filter as a functional 
surface with a high capture efficiency. We have also demonstrated 
the effectiveness of the method to deliver quantitative results which 
are statistically similar to the established method within the required 
range. Two phage-based filtration assays were compared to the 
current 24-hour EPA method and yielded similar results in only 
10 hours. Given that phages exist for almost all bacteria, this method 
can be modified for other pathogens and indicators in other liquid 
samples such as urine, beverages, and environmental waters. 
The use of reporter probes with fusion tags, which enable them to 
bind the filter, allowed the labeling of the individual CFU locations, 
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and prevented the bleeding and overlapping of the enzyme product. 
The discrete localization of the enzyme product in proximity to the 
lysed bacterial cells allowed the counting of the individual CFUs and 
thus enabling quantification. As with all methods, higher bacterial 
concentrations resulted in overlapping colonies that leads to natural 
variations in counts. While the 47 mm filters used in the assay are 
recommended for < 100 CFU in order to reduce the frequency of 
overlapping colonies, larger filters could be used to allow for a larger 
dynamic range. 
Given the practical limitations of isolating a single viable CFU for the 
validation of single CFU detection ability of an assay, we performed 
a direct comparison between our proposed methods and the 
established EPA method using the same inoculated water samples. 
From these results, similar variability within all assay formats was 
observed. 
By using the engineered phages and reporter probes with cellulose-
affinity, we have incorporated the filter material into the signal 
generation and readout. This resulted in a lab-on-a-filter that could 
be used to identify discrete CFUs from large samples in a 
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significantly shorter time than the current standard. As will all 
bacterial detection assays, a high degree of specificity is critical. In 
order to ensure the proper host range, phage-based assays and 
therapeutics commonly use cocktails of phages with differing 
specificities. In the future, the ability to use genetic engineering to 
engineer the host range of phages will have a significant impact on 
their utility. In the assay presented in this report, we selected a single 
E. coli isolate to demonstrate the detection platform. The isolate, 
ECOR #13, was isolated from a human and therefore represents an 
indicator of fecal contamination. While a field-ready version of this 
assay would most likely require a cocktail of engineered phages for 
the appropriate host range, we have demonstrated a proof of 
principle for an assay format which could enable faster field testing 
than those currently used in the field which require up a minimum of 
24 hours to achieve quantitative results. 
 140 
REFERENCES 
1. United Nations. In A/RES/64/292(ed United Nations General 
Assembly) (2002).  
2. WHO. WHO estimates of the global burden of foodborne 
diseases 2007–2015. (World Health Organization 2015).  
3. Barantsevich, E. et al. Etiological agents of bacterial sepsis in a 
newly constructed medical center in Saint Petersburg, Russia. 
Critical Care 15, P45–P45,  https://doi.org/10.1186/cc10414 (2011). 
4. Stoll, B. J. et al. Early Onset Neonatal Sepsis: The Burden of 
Group B Streptococcal and E. coli Disease Continues. Pediatrics 
127, 817–826,  https://doi.org/10.1542/peds.2010-2217 (2011). 
5. In EPA-821-R-02-024 (ed Office of Water) (United States 
Environmental Protection Agency, 1200 Pennsylvania Avenue, NW 
Washington, DC 20460, 2002).  
6. FDA.gov. FSMA Final Rule on Produce Safety, 
http://www.fda.gov/Food/GuidanceRegulation/FSMA/ucm334114.ht
m (2016).  
7. FDA. Vol. 111-353 (Washington D.C., 2011).  
 141 
8. FDA. Guidance for Industry: Guide to Minimize Microbial Food 
Safety Hazards of Fresh-cut Fruits and Vegetables 
http://www.fda.gov/food/guidancecomplianceregulatoryinformation/
guidancedocuments/produceandplanproducts/ucm064458.htm. 
Vol. 2010 (2010).  
9. Wright, J., Gundry, S. & Conroy, R. Household drinking water in 
developing countries: a systematic review of microbiological 
contamination between source and point-of-use. Tropical Medicine 
& International Health 9, 106–117,  https://doi.org/10.1046/j.1365-
3156.2003.01160.x (2004). 
10. Edberg, S. C., Rice, E. W., Karlin, R. J. & Allen, M. J. 
Escherichia coli: the best biological drinking water indicator for public 
health protection. Journal of Applied Microbiology 88, 106S–116S 
(2000). 
11. Food, U. & Administration, D. Food safety modernization act 
(FSMA). Public Law 2011, 111–353 (2011).  
12. USEPA, E. Method 1603: Escherichia coli (E. coli) in water by 
membrane filtration using modified membrane-thermotolerant 
 142 
Escherichia coli agar (modified mTEC). (EPA 821-R-02-023, US 
Environmental Protection Agency, Washington [DC], 2002).  
13. Zhang, D. et al. The Use of a Novel NanoLuc -Based Reporter 
Phage for the Detection of Escherichia coli O157:H7. Sci Rep 6, 
33235,  https://doi.org/10.1038/srep33235 (2016). 
14. Jackson, A. A., Hinkley, T. C., Talbert, J. N., Nugen, S. R. & 
Sela, D. A. Genetic optimization of a bacteriophage-delivered 
alkaline phosphatase reporter to detect Escherichia coli. Analyst  
https://doi.org/10.1039/C6AN00479B (2016). 
15. Born, Y. et al. Engineering of Bacteriophages Y2::dpoL1-C and 
Y2::luxAB for Efficient Control and Rapid Detection of the Fire Blight 
Pathogen, Erwinia amylovora. Appl Environ Microbiol 83,  
https://doi.org/10.1128/AEM.00341-17 (2017).  
16. Sergueev, K. V., Filippov, A. A. & Nikolich, M. P. Highly 
Sensitive Bacteriophage-Based Detection of Brucella abortus in 
Mixed Culture and Spiked Blood. Viruses 9,  
https://doi.org/10.3390/v9060144 (2017). 
 143 
17. Chen, J., Alcaine, S. D., Jackson, A. A., Rotello, V. M. & Nugen, 
S. R. Development of Engineered Bacteriophages for Escherichia 
coli Detection and High-Throughput Antibiotic Resistance 
Determination. ACS Sens 2, 484–489,  
https://doi.org/10.1021/acssensors.7b00021 (2017). 
18. Rippa, M. et al. Octupolar Metastructures for a Highly Sensitive, 
Rapid, and Reproducible Phage-Based Detection of Bacterial 
Pathogens by Surface-Enhanced Raman Scattering. ACS Sens 2, 
947–954,  https://doi.org/10.1021/acssensors.7b00195 (2017). 
19. Kim, J., Kim, M., Kim, S. & Ryu, S. Sensitive detection of viable 
Escherichia coli O157:H7 from foods using a luciferase-reporter 
phage phiV10lux. Int J Food Microbiol 254, 11–17,  
https://doi.org/10.1016/j.ijfoodmicro.2017.05.002 (2017). 
20. Alcaine, S. D. et al. Bioengineering bacteriophages to enhance 
the sensitivity of phage amplification-based paper fluidic detection of 
bacteria. Biosens Bioelectron 82, 14–19,  
https://doi.org/10.1016/j.bios.2016.03.047 (2016). 
 144 
21. Chen, J., Alcaine, S. D., Jiang, Z., Rotello, V. M. & Nugen, S. R. 
Detection of Escherichia coli in Drinking Water Using T7 
Bacteriophage-Conjugated Magnetic Probe. Anal Chem 87, 8977–
8984,  https://doi.org/10.1021/acs.analchem.5b02175 (2015). 
22. Alcaine, S. D. et al. Phage-protease-peptide: a novel trifecta 
enabling multiplex detection of viable bacterial pathogens. Applied 
microbiology and biotechnology 99, 8177–8185 (2015). 
23. Burnham, S. et al. Towards rapid on-site phage-mediated 
detection of generic Escherichia coli in water using luminescent and 
visual readout. Anal Bioanal Chem 406, 5685–5693,  
https://doi.org/10.1007/s00216-014-7985-3 (2014). 
24. Hall, M. P. et al. Engineered luciferase reporter from a deep sea 
shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem 
Biol 7, 1848–1857,  https://doi.org/10.1021/cb3002478 (2012). 
25. Ji, B.-J., Song, G., Zhang, Z. & Guo, Z.-Y. Efficient 
overexpression of human interleukin-6 in Escherichia coli using 
nanoluciferase as a fusion partner. Process Biochemistry 50, 1618–
1622,  https://doi.org/10.1016/j.procbio.2015.06.008 (2015). 
 145 
26. Muller, B. H. et al. Improving Escherichia coli alkaline 
phosphatase efficacy by additional mutations inside and outside the 
catalytic pocket. Chembiochem 2, 517–523, 
https://doi.org/10.1002/1439-7633(20010803)2:7/8<517::AID-
CBIC517>3.0.CO;2-H (2001). 
27. Rosenberg, A. et al phage display system: a powerful new 
protein display system based on bacteriophage T7. Innovations 1–6 
(1996).  
28. Dai, M. et al. Using T7 phage display to select GFP-based 
binders. Protein Engineering Design & Selection 21, 413–424,  
https://doi.org/10.1093/protein/gzn016 (2008). 
29. Gamkrelidze, M. & Dabrowska, K. T4 bacteriophage as a phage 
display platform. Arch Microbiol 196, 473–479,  
https://doi.org/10.1007/s00203-014-0989-8 (2014). 
30. Loessner, M. J., Rees, C. E., Stewart, G. S. & Scherer, S. 
Construction of luciferase reporter bacteriophage A511::luxAB for 
rapid and sensitive detection of viable Listeria cells. Applied and 
Environmental Microbiology 62, 1133–1140 (1996). 
 146 
31. Ikeda, R. A. The efficiency of promoter clearance distinguishes 
T7 class II and class III promoters. J Biol Chem 267, 11322–11328 
(1992). 
32. Tian, T. & Salis, H. M. A predictive biophysical model of 
translational coupling to coordinate and control protein expression in 
bacterial operons. Nucleic Acids Res 43, 7137–7151,  
https://doi.org/10.1093/nar/gkv635 (2015). 
33. McLean, B. W. et al. Analysis of binding of the family 2a 
carbohydrate-binding module from Cellulomonas fimi xylanase 10A 
to cellulose: specificity and identification of functionally important 
amino acid residues. Protein Eng 13, 801–809 (2000). 
34. Oliveira, C., Carvalho, V., Domingues, L. & Gama, F. M. 
Recombinant CBM-fusion technology - Applications overview. 
Biotechnol Adv 33, 358–369,  
https://doi.org/10.1016/j.biotechadv.2015.02.006 (2015).  
 
 
 147 
CHAPTER 5 
A SYRINGE-BASED BIOSENSOR TO RAPIDLY DETECT LOW 
LEVELS OF ESCHERICHIA COLI IN DRINKING WATER USING 
ENGINEERED BACTERIOPHAGES* 
 
 
 
 
 
 
 
 
 
 
 
* Troy C. Hinkley, Sangita Singh, Spencer Garing, Anne-Laure M. Le 
Ny, Kevin P. Nichols, Joseph E. Peters, Joey N. Talbert, & Sam R. 
Nugen 
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ABSTRACT 
A sanitized drinking water supply is an unconditional requirement for 
public health and the overall prosperity of the human race.  Potential 
microbial and chemical contaminants of drinking water have been 
identified by a joint effort between the World Health Organization 
(WHO) and the United Nations Children’s Fund (UNICEF) who 
together establish guidelines that define, in part, that the presence 
of Escherichia coli in drinking water is an indication of inadequate 
sanitation and a significant health risk. 
As Escherichia coli is a nearly ubiquitous resident of mammalian GI 
tracts, no detectable counts of such an organism in 100 mL drinking 
water is the standard used worldwide as an indicator of sanitation.   
One important threshold requires that 100 mL of drinking water 
contain no detectable Escherichia coli (E. coli).  In response, we 
developed a rapid bacteriophage-based detection assay with 
detection limit capabilities comparable to traditional methods in less 
than a quarter of the time. 
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We coupled membrane filtration with selective enrichment using 
genetically engineered bacteriophage (phage) to identify less than 
20 CFU E. coli in 100 mL drinking water in 5 hours.   
The combination of membrane filtration with phage infection 
produced a novel assay that demonstrated the rapid, selective and 
sensitive detection of an indicator organism in large volumes of 
drinking water as recommended by the leading world philanthropic 
organizations.   
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INTRODUCTION 
Every person on the planet has a fundamental human right to water 
and sanitation.1  Unfortunately, millions still lack access to potable 
water sources within reasonable walking distance from their homes.2  
Not only does microbial contamination of drinking water contribute 
significantly to morbidity and mortality worldwide, it disproportionally 
affects members of low income countries.3  Improper sanitation of 
drinking water sources is strongly correlated with the presence of 
coliforms (a widely variable group of gram-negative rod shaped 
bacteria that possess a range of biochemical attributes4).  
Escherichia coli (E. coli) is a member of the coliform family, is a near 
ubiquitous resident of mammalian GI tracts5 and thus has been 
determined an appropriate indicator of fecal pollution from warm-
blooded animals.  In 2015, even though over 5 billion people were 
lucky enough to utilize water sources free from contamination, 
almost 850 million people still lacked access to a basic drinking 
water source.6  Of those 850 million people, children typically bear 
the brunt of the disease burden as their developing immune systems 
cannot effectively eradicate ingested coliforms in improperly 
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sanitized drinking water.7  The resulting diarrheal disease typically 
results in severe dehydration, a condition that necessitates a clean 
drinking water source for improvement in well-being.  More 
specifically, E. coli is responsible for nearly a third of neonatal sepsis 
cases8 and the majority of urinary tract infections worldwide.9   
Even though the detection any indicator species will have inherent 
limitations and biases,10 the detection of E. coli as an indication of 
poor sanitation has been widely successful in the improvement of 
water supplies worldwide.2, 11-14  While standard culture-based 
techniques are reliable, results require anywhere from 24 to 72 
hours,15, 16 a relative eternity for a community water supply in require 
of remediation.17 
The rapid detection of bacteria remains a significant challenge and 
many research approaches have been developed to overcome that 
challenge.18  One promising area of rapid microbial detection assays 
are bacteriophage-based diagnostics.19  Bacteriophages (phages) 
are obligate bacteria-infecting viruses that have co-evolved with 
bacteria for most (if not all) of the more 3 billion years that bacteria 
have existed on the planet.20  Reporter phages have been modified 
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to include an exogeneous reporter gene in the phage genome.   The 
newly created recombinant phage expresses the exogenous cellular 
biomarker upon phage infection in addition to new phage progeny.21  
Measurement of the reporter enzyme activity allows for correlation 
between signal output (absorbance, fluorescence, luminescence, 
etc.) and initial bacterial populations.    
The field of bioluminescence has been advancing for 70 years, from 
McElroy’s pioneering work 22 to the development and widespread 
implementation of the NanoLuc luciferase.23-33   
Luminescent reporter phages have been developed for the sensitive 
detection of common foodborne pathogens such as Escherichia coli, 
24, 34, 35 Listeria monocytogenes,36 Salmonella Typhimurium,37 
Mycobacterium tuberculosis,38 Vibrio parahaemolyticus,39 among 
others.40-45  The NanoLuc reporter is uniquely suited for sensitive 
detection assays as it conferse a low background signal coupled with 
high dynamic range.33 
In addition, the orthogonality of the NanoGlo chemical substrate 
system33 offers consistently low background levels in a wide range 
of sample conditions, a characteristic pointing its use towards low 
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cost implementation. As sensitivity increases, distinguishing signal 
from noise becomes a major challenge in the establishment of the 
limit of detection. 
The selective nature of phages is well documented,46 and therefore 
our phage-based detection assay is well suited in situations where 
indicators and/or pathogen detection is pertinent.47  To create the 
recombinant phages used in our novel detection platform, we 
inserted an enzyme expression cassette into a wild type phage 
genome to force expression of a heterologous reporter enzyme in 
addition to new phage progeny upon phage infection.  The NanoLuc 
enzyme was selected as our reporter enzyme as it is more than 100x 
more active than its luminescent counterparts,33 and this highly 
active reporter enzyme is already widely deployed in a variety of 
detection assays25, 26, 31, 32 including bacteriophage-based 
schemes.24, 48, 49  The NanoLuc enzyme was further functionalized 
by genetically fusing a cellulose binding module (CBM) to the C-
terminus of the NanoLuc reporter gene.  The CBM selected for this 
work (CBM2a) has previously been fused to a dimeric reporter 
enzyme (Alkaline Phosphatase) that allows for successful 
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immobilization on cellulose while still retaining enzymatic activity.50  
In comparison, NanoLuc is a much smaller, monomeric reporter that 
is frequently utilized as a genetic fusion tag.   
Upon phage infection, the expression levels of the reporter enzyme 
have a direct effect upon the limit of detection as fewer cells are 
required to produce enough reporter for the signal to rise above the 
detection limit.  As a result, we modified the upstream regulatory 
regions of the reporter enzyme cassette to determine the optimal 
sequences that permit the detection of the fewest concentration of 
cells.  
Herein we propose a rapid (5 h) bacteriophage-based approach for 
the sensitive detection of the indicator bacteria Escherichia coli, the 
target of many regulatory requirements.51  The novel detection assay 
coupled membrane filtration with bacteriophage infection to 
generate a luminescent signal if viable Escherichia coli were 
present. The combination of sample concentration with heterologous 
reporter enzyme expression upon bacteriophage infection produced 
a detection limit of less than 20 CFU in 100 mL of drinking water. 
MATERIALS & METHODS 
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Materials & Reagents 
NanoGlo (luminescent substrate) was purchased from Promega 
(Madison, WI, USA) and prepared immediately prior to use.  
Regenerated cellulose filters (diameter 13 mm, pore size 0.2 µm) 
were fitted within polycarbonate reusable syringe filter housings 
(Sartorious Stedim Biotech GmbH, Goettingen, Germany) and 
autoclaved prior to use in detection assays.  Assembled, autoclaved 
filters were fitted to sterile single use syringes (100 mL, Wilburn 
Medical, Kernersville, NC, USA) to perform filtration.  All other 
reagents were purchased from Sigma Aldrich (St. Louis, MO, USA). 
Bacterial Strains & Growth Conditions 
Escherichia coli BL21 was obtained from ATCC (Manassas, VA, 
USA) and E. coli ECOR13, a reference strain of E. coli isolated from 
a healthy human, was obtained from the Thomas. S. Whittam STEC 
Center (East Lansing, MI, USA).  Bacterial stocks were stored at -80 
°C in 25% glycerol prior to use and cultured in Luria Bertani high salt 
(LB) broth and plated on LB agar.  Overnight cultures of E. coli BL21 
and E. coli ECOR13 were cultivated in Luria-Bertani medium (12-16 
hours, 37 °C, 250 rpm).  The concentration of E. coli ECOR13 used 
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in detection assays was determined by standard plate counts on LB 
agar (24 hours, 37 °C).   
Bacteriophage T7 was propagated on E. coli BL21 using standard 
protocols.  Briefly, an overnight culture of E. coli BL21 was 
subcultured in LB (200 mL, 37 °C, 250 rpm, ~2 hours) and grown to 
mid exponential phase (OD600 = 0.6).  Phages were added to the 
bacterial culture at a multiplicity of infection (MOI) of 0.1, and 
incubated (37 °C, 250 rpm) until lysis was observed (~2 hours).  
Cellular debris was removed via centrifugation (3,200 x g, 10 min, 4 
°C) before sterile filtration (0.22 µm).  Phage particles were 
precipitated by overnight incubation (4 °C, 18 hours) with 
polyethylene glycol 6000 (PEG6000, 4%) and sodium chloride 
(NaCl; 0.4 M) before ultracentrifugation (35,000 x g, 120 min, 4 °C).  
Phage were resuspended in phosphate buffered saline (1x PBS, pH 
7.4) and stored at 4 °C.  Standard double agar overlay assays were 
used to enumerate phage samples.52  Phage stock solutions used in 
detection assays were diluted to 109 PFU/mL in LB, sterile filtered 
(0.22 µm) and stored at 4 °C. 
 157 
DNA Isolation 
DNA was prepared in accordance with standard procedures.53  
Briefly, concentrated phage stocks (5 mL, >1011 PFU/mL) were 
treated with sodium dodecyl sulfate (5 mL; 4%) at 70 °C for 20 
minutes before cooling on ice.  Potassium acetate (5 mL, 2.55 M, pH 
4.8) was added, the samples were centrifuged (10 min, 10,000 x g, 
4 °C) and the supernatant was applied to an anion exchange resin 
(Qiagen Genomic Tip 100/G) in accordance with the manufacturer’s 
specifications. 
Recombinant Phage Construction 
The optimized NanoLuc-CBM fusion reporter gene was inserted into 
the genome of T7Select to create reporter bacteriophage NRGp5. 
Integration of the gene was performed using homologous 
recombination as previously described.48  Briefly, the T7Select 
genome was prepared as a cloning vector by propagation of the 
phage in E. coli BL21, followed by purification and restriction 
digestion of the genome to generate two vector arms.  Homology to 
the upstream and downstream regions of the insertion site were 
included at the N and C terminal ends of the reporter gene fragment, 
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respectively. The three DNA fragments consisting of the reporter 
gene and two vector arms were assembled using in vitro DNA 
assembly (New England Biolabs, Ipswich, MA, USA). The 
assembled DNA was then transformed into E. coli (MegaX DH10B, 
Thermofisher), and incubated for 120 minutes until visible lysis 
occurred. The mutant T7 (NRGp5) was identified using a plaque 
assay followed by application of NanoGlo substrate (Promega, 
Madison WI, USA) on individual plaques. The pate was then imaged 
with a 30 second exposure time (Rebel T6, Canon, Melville NY, 
USA) in a dark box (LTE-13, Newport Corporation, Irvine, CA, USA) 
to identify luminescent plaques. The mutants were isolated and 
propagated on E. coli BL21 in accordance with standard 
techniques.52 
Phage characterization 
The genomes from the NRGp5 phages were isolated and submitted 
for sequencing. Characterization of the phage infection was 
compared to the original T7Select. The phage host E. coli ECOR13 
was grown from stationary phase in LB media (3 h, 37 °C, 250 rpm) 
using 24 well microplates (Greiner Bio-One North America Inc., 
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Monroe, NC, USA). The optical density at 600 nm (OD600) was 
determined at periodic time intervals to observe the growth of the 
bacterial cells. Phage addition (negative control, 107 PFU/mL 
T7Select, or 107 PFU/mL NRGp5) took place at 180 minutes and the 
optical density (OD600) was monitored for 300 minutes using a 
Synergy Neo2 microplate reader (Biotek Instruments, Winooski, VT, 
USA). 
The luminescence during the phage infections was monitored for a 
negative control, T7Select, NRGp5, as well as a previously 
developed NRGp4.48 Luminescent signals were measured using the 
same microplate reader (Biotek Instruments, Winooski, VT, USA) in 
sterile 24 well suspension culture plates (Cellstar, Greiner Bio-One, 
Monroe, NC, USA) with a 0.1 s integration time. To approximate 
growth conditions in the detection assay, the host E. coli ECOR13 
was grown from stationary phase in LB supplemented with NanoGlo 
(3 h, 37 °C, 250 rpm). Phage addition took place at 180 minutes and 
luminescence was measured at 30 minute intervals for 300 minutes. 
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Dose response 
The sensitivity of phage NRGp5 to differentiate concentrations of 
bacteria in growth media was evaluated.  Phage NRGp5 (107 
PFU/mL) was added to serial dilutions of mid-exponential phase E. 
coli ECOR13 (0 to 105 CFU/mL) and incubated (1.5 h, 37 °C) for to 
allow the phage infection to proceed.  Aliquots were mixed 1:1 with 
NanoGlo substrate and luminescence was measured on a plate 
reader. Bacterial concentrations were confirmed using standard 
plate counts. 
Infection of non-viable cells 
The ability of phage NRGp5 to differentiate between viable and 
nonviable bacterial cells was evaluated by treating identical cultures 
with either alcohol (inactivation) or a biological buffer (control) before 
phage infection.  Briefly, E. coli ECOR13 was harvested at mid-
exponential phase (OD600 = 0.5), separated into identical aliquots, 
and centrifuged (3,000 x g, 5 min).  The cell pellet was resuspended 
in either ethanol (70%) or phosphate buffered saline (PBS; 1x) and 
incubated at room temperature for 10 minutes.  The cells were 
pelleted again (3,000 x g, 5 min), resuspended in sterile autoclaved 
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drinking water (100 mL, 20 °C) and used as analytical samples for 
the phage-based diagnostic assay. 
Phage-Based Syringe Filter Detection Assay 
An overall detection scheme can be seen in Figure 1. Drinking water 
was autoclaved to account for any natural flora before aliquots (100 
mL) were deliberately spiked with known concentrations of E. coli 
ECOR13.  Samples were then passed through 0.22 µm regenerated 
cellulose filters (Sartorious Stedim Biotech GmbH, Goettingen, 
Germany) to separate the bacteria. The filters were removed and 
incubated on LB media (3 h, 37 °C) in order to resuscitate the 
bacteria.  Phage NRGp5 (107 PFU/mL) was applied to the enriched 
bacteria on the filter and incubated (1.5 h, 37 °C) for expression of 
the luminescent reporter.  The filters were fully submerged in 
NanoGlo substrate and luminescence was measured every 12 
seconds for 5 minutes in a spectrophotometer to capture peak signal 
generation.  The variability of the blank was used to calculate the 
limit of detection using the standard method of adding three times 
the standard deviation of the blank to the mean blank value. 
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Figure 1: Scheme for the detection of E. coli in drinking water. a) The water is filtered 
through a 0.22 µm cellulose filter in order to separate the bacteria. b) The filter is then 
removed from the housing and placed on LB media in order to resuscitate the trapped 
bacteria. c) Following the application of the engineered phages (grey), an infection 
cycle results in the expression and release of a reporter enzyme consisting of NanoLuc 
(blue) and a carbohydrate binding module (orange) with specificity to cellulose. d) The 
fusion enzyme binds to the cellulose filter and the luminescent activity can then be 
determined. 
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RESULTS & DISCUSSION 
Recombinant phage construction 
The newly developed luciferase, NanoLuc, was selected as a 
preferred reporter because it is a small, highly active, monomeric 
enzyme.33  The 19 kDa luciferase was genetically fused to a 
carbohydrate binding module to create a 31 kDa fusion enzyme.  
This novel fusion reporter has demonstrated the simultaneous 
capability to generate a luminescent signal while specifically bound 
to a cellulosic substrate. The whole genome sequencing revealed 
no mutations to the insertion cassette as well as no insertions, 
deletions or significant mutations outside of the cloning site. 
Phage Characterization 
The successful insertion of the reporter gene was determined by 
visualizing the luminescence of phage plaques. Reporter gene 
expression was initially confirmed via long exposure photography of 
double overlay plaque assays where NanoGlo substrate was directly 
applied to well isolated plaques. Luminescent plaques were isolated 
and propagated for detection assays and submitted for whole 
genome sequencing.  The ability of phage NRGp5 to infect and lyse 
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indicator bacteria was directly compared to the original T7Select in 
order to evaluate if the addition of the reporter enzyme gene had a 
deleterious effect on the apparent fitness of the phage.  As seen in 
Figure 2, there was no statistical difference between the 
magnitudes, or rate of optical density decrease, resulting from 
addition of the two phage types.  Insertion of the NanoLuc-CBM 
reporter was performed in an intergenic region immediately 
downstream of the capsid without any native gene knockouts, as 
confirmed by whole genome sequencing. The genetic insertion 
served to increase the genome size of T7Select by less than 3% 
(37.3 kb vs. 38.3 kb) leaving it with a genome still smaller (~38kb) 
than that of its 39.7kb wild type counterpart.54   
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Figure 2: Phages (NRGp5 or T7Select) were added to individual cultures of E. coli 
(ECOR13) after 3 hours of enrichment. The E. coli in samples without phages added 
continued to exponential phase while the application of phage resulted in a decline in 
optical density after about two hours. There was no statistical differences in the 
infection characteristics between the two phages. 
 166 
During phage infection, T7 DNA is replicated in concatemers and 
successful phage maturation relies on the specific recognition and 
cleavage of cos sites located at the termini of each genomic copy.  If 
the genetic insertion is too large then progeny phages will be unable 
to fit the genome into the limited space within the capsid. 
Packing of the modified genome into the capsid was not expected to 
cause a significant loss in fitness as larger reporters have previously 
been inserted into T7 with no apparent lack of fitness.55, 56 Figure 3 
suggests that only cultures infected with phage NRGp4 or NRGp5 
produced luminescent signals above the limit of detection.  While 
changes to the promoter and ribosome binding sites upstream of the 
reporter only served to decrease luminescence signal during the 
infection of identical cultures (data not shown), removal of the N-
terminal secretion signal used in phage NRGp4 48 produced nearly 
a half log increase in signal intensity (Figure 3) when identical 
cultures were infected.  
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Figure 3: Luminescence was measured from E. coli samples with and without the 
phages T7Select, which did not contain a gene for a reporter enzyme, NRGp4, which 
contained a gene for NanoLuc-CBM, and NRGp5, which contained an optimized 
NanoLuc-CBM gene. It can be seen that the reporter genes resulted in luminescence 
with the optimized gene providing a higher signal. The lowest positive signal was 
calculated as the negative control +3x the standard deviation using a minimum of three 
replicates. 
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The results suggest that the newly developed reporter phage 
NRGp5 is a viable candidate for use as a more sensitive biosensor 
element in the phage-based detection assay. 
Dose Response 
The phage NRGp5 was also used to infect E. coli ECOR13 at 
varying bacterial concentrations (Figure 4). The results suggested a 
relatively linear response between 100 – 105 CFU/mL. This broad 
dynamic range in a detection scheme is common for the NanoLuc 
reporter enzyme that has shown a dynamic range over 8 orders of 
magnitude.33 A limit of detection (LOD) was determined using a 
lowest positive luminescence of the average negative control 
background plus three times its standard deviation (0+3SD). As 
shown in Figure 4 an LOD between 10 and 100 CFU/mL can be 
achieved using NRGp5 and ECOR13 in bulk media without any 
filtration or enrichment. 
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Figure 4: NRGp5 was added at a high MOI to varying concentrations of E. coli ECOR13. 
The luminescence of the lysate resulting from the infections was determined following 
the addition of substrate. The increase in signal was relatively linear to the initial log 
concentration of bacteria suggesting a broad dynamic range.  From these experiments, 
a limit of detection between 10 and 100 CFU/mL was determined. The lowest positive 
signal was calculated as the negative control + 3x the standard deviation using a 
minimum of three replicates. 
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Infection of non-viable cells 
Because drinking water often undergoes treatment steps in order to 
kill potentially harmful pathogens, the ability to distinguish between 
viable and non-viable bacterial is critical for reliable results. Given 
that phages utilize the genetic machinery of the host bacteria for 
successful replication, it was not expected that NRGp5 could 
replicate in non-viable cells. In order to determine if the assay is able 
to distinguish between viable and non-viable bacterial cells, E. coli 
ECOR13 cells were treated with 70% ethanol and washed prior to 
analysis. As demonstrated in Figure 5, only phages added to non-
ethanol treated cells were able to produce luminescence following 
substrate addition while bacterial cells treated with ethanol did not 
produce luminescence following phage addition. 
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Figure 5: In order to demonstrate the ability of the phage-based assay to distinguish 
between viable and non-viable  
E. coli ECOR13 cells, the bacterial cells were exposed to either 70% ethanol or PBS, 
and washed. The cells were then either infected with NRGp5 or incubated without 
phage. The only variant to display luminescence following incubation and substrate 
addition was the non-ethanol treated E. coli ECOR13 with the NRGp5 phages. 
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Phage-Based Syringe Filter Detection Assay 
We improved the limits of detection achieved in bulk media without 
enrichment by adding filtration and enrichment steps prior to phage 
infection.  The limit of detection improved by several orders of 
magnitude from ~100 CFU per mL (Figure 4) to 10 to 20 CFU per 
100 mL (Figure 6).  While positive signals were detected for fewer 
bacterial cells, the variability of those results did not render the 
reproducibility required for an acceptable proportion of false 
negative outcomes.  Nevertheless, our novel detection assay 
realized multiple improvements in limits of detection over previously 
developed technology and approaches the limits of detection of 
standard culture based techniques in much less time. 
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Figure 6.  Performance of the phage-based syringe filter detection assay.  Water 
(100mL) was processed through a syringe filter (0.22um, regenerated cellulose) where 
bacteria (E. coli ECOR13) were enriched prior to the addition of phage NRGp5.  
Reporter enzymes were expressed, immobilized onto the filter, and luminescence was 
measured.  
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Further improvements to the limit of detection at these bacterial 
concentrations is increasingly challenging due to the inherent nature 
of bacterial cells in large sample volumes.  Unlike fully miscible 
solutes, bacterial cells are discreet units incapable of nearly infinite 
dilution and this effect is illustrated in Figure 6 as the horizontal error 
bars increase in size as cell populations decrease. 
CONCLUSION 
The presented research displays a specific, rapid and effective 
detection assay for indicator E. coli in large drinking water samples 
based on heterologous enzyme expression via bacteriophage 
infection.  The specific advantages of phages make them excellent 
candidates as biorecognition elements.  Not only are phage 
incredibly species specific, they are also capable of differentiating 
between live and nonviable cells. 
We have demonstrated the successful insertion of a reporter 
enzyme cassette into a bacteriophage genome to create the reporter 
phage NRGp5.  This recombinant phage forced the overexpressed 
of a highly active bifunctional reporter enzyme that was immobilized 
onto a regenerated cellulose membrane filter and facilitated the 
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rapid detection of low numbers of indicator bacterial cells.  
Improvements in enzymatic activity and expression as well as phage 
host range will serve to create a robust and sensitive detection assay 
with potential to improve the lives of people around the world. 
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